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Objective: Recent improvements in hospital care have come from a growing knowledge 
of factors that contribute to readmission. The objective of this work is to identify and 
describe the national readmission rate after Total Joint Arthroplasty, and to evaluate 
selected hospitals’ and patients’ factors for their association with the all-cause 30-day 
readmission rate after TJA in the United States in 2014. 
Method: Retrospective analysis of 938,504 TJA acute care hospital discharge records was 
performed, using a nationally representative database that is dedicated to the study of 
hospital readmissions, and accounts for 51% of total US hospitalizations. Logistic 
regression models were used to analyze patient characteristics, discharge disposition, 
and hospital factors associated with all-cause 30-day hospital readmission. 
Results: The national rate of 30-day readmissions after TJA was 4%. A patient’s age, 
gender, type of insurance, discharge destination, and DRG severity were all significantly 
associated with readmission, at (p < 0.0001). Female patients had a 22% lower risk of 
readmission than the males. Patients who had Medicare as the primary payer had 34% 
higher risk, and those with Medicaid had a 74 % higher risk, while patients with other 
types of insurance, such as worker's compensation or other government programs, were 
at a 27% higher risk for readmission when compared to patients with commercial 
insurance. Patients discharged to a skilled nursing or intermediate care facility had a 61%  
vi 
 
higher risk for hospital readmission, while those who were discharged to home health-
care services had a 10% higher risk for readmission when compared to patients 
discharged to home with no further medical services. TJA patients discharged home tend 
to have the lowest rates of 30-day readmission. Additionally, patients who receive post-
acute care services at home are less likely to be readmitted to the hospital compared 
with those who receive post-acute care at inpatient settings, such as skilled nursing or 
intermediate care facilities. 
Discussion:  Studying risk factors associated with hospital readmissions, potential 
interventions, and related measurements is important to create effective programs that 
improve patient clinical outcomes, and design fair adjusted payment incentives that 
favorably affect healthcare cost and quality of care. Adjusting risk to account for patient 
characteristics, hospital factors, and post-acute care is essential for designing provider 
incentives that reduce hospital readmission and avoid unintended consequences. Also, a  
stratification of patients can be used to identify those at higher risk of readmission so 
that a greater intensity of intervention can be used to avoid readmissions. 
Key Words: Readmissions, Rehospitalizations, Total Joint Arthroplasty, Comprehensive 
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In recent years, there has been a dramatic increase in the orthopedic surgical 
procedures performed in the United States, particularly joint arthroplasty. Between 2003 
and 2012, knee arthroplasty and hip replacement were in the top five operating room 
procedures performed for adults aged 45 years and older, with an average annual 
increase of 2.9% for hip replacement, and a 4.9% increase for knee arthroplasty for all 
age groups, far outpacing the average annual population growth rate of 0.88% during the 
same 10-years period1. (Table 1.1) from the Healthcare Cost and Utilization Project 
(HCUP) statistical brief presents procedures with the greatest change in rate per 100,000 
population between 2003 and 2012 (Steiner, Carol, Audrey, & Claudia, 2014). Five of the 
first six procedures were related to the musculoskeletal system. 




Operating room procedure 
Stays, n 
Rate per 100,000 
population 
Average annual % 
change in rate, 
2003–2012 2003 2012 2003 2012 
 Procedure (greatest increase in rate) 
1 Gastrectomy, partial and total 26,900 74,100 9.3 23.6 10.9 
2 Arthroplasty knee 421,700 700,100 145.4 223.0 4.9 
3 Arthroplasty other than hip or knee 55,900 90,000 19.3 28.7 4.5 
4 Partial excision bone 232,500 338,000 80.1 107.7 3.3 
5 Spinal fusion 316,00 450,900 108.9 143.6 3.1 







The growth in demand for joint arthroplasty is expected to continue to increase over the 
next twenty years; current projections estimate that; by 2030 the demand for total hip 
arthroplasties will grow by 174 percent, which equals 572,000 per year, while the 
demand for total knee arthroplasties will increase by 673 percent, which is 3.48 million 
procedures per year, nearly a 7-fold increase (S. Kurtz, Ong, Lau, Mowat, & Halpern, 
2007). This increase will generate a significant expenditure in the American healthcare 
system; since 2005, the cost of TKA has risen more than 5 times, to $40.8 billion, and the 
cost of THA has risen more than 4 times, to $13.43 billion (S. M. Kurtz et al., 2007). 
Increase in demand coupling with this price tag makes TJA the single largest cost in the 
Medicare budget (Li, Lu, Wolf, Callaghan, & Cram, 2013). 
The increase in joint replacement arthroplasty can be viewed as an indication of 
the success of this procedure in safely reducing pain and improving patient’s quality of 
life. However, hospital readmission following TJA hospitalization has increased in the last 
15 years. Cram and colleagues report an increase in 30-day all-cause readmission for 
Medicare population undergoing total hip arthroplasty from 5.9% to 8% between 1991 
and 2008 (Cram et al., 2011), they also report an increase in the 30-day all-cause 
readmission rates from 4.2% to 5.0% after knee arthroplasty between 1991 and 2010 
(Cram et al., 2012). The most recent report on the 30-day all-cause hospital readmission 
rate after TJA hospitalization is 4% (S. M. Kurtz et al., 2017b). Inadequate care transitions 
planning, bad communication , and delays in scheduling post care services are among the 





Hospital readmissions are difficult for patients and costly for hospitals. Hospital 
readmissions usually associated with poor outcomes for patients, payer, and provider. 
Higher rates of hospital readmission can reflect suboptimal quality of care during the 
index stay, and a lack of coordination among health care providers and patients in the 
transition to home or another post-discharge care setting. Health care providers have 
adopted a wide variety of strategies to lower hospital readmission but with mixed results 
(Dundon et al., 2016; King et al., 2017). Research suggests that, hospital readmission can 
be reduced through the adoption of quality initiatives, disease management programs, 
and by interventions that improve the transition between health care settings. However, 
the U.S healthcare prospective payment system fee-for-service has been insufficient to 
incentivize collaboration and coordination across care settings and between various 
health care providers. 
Payers and policy makers are working cooperatively to find ways to improve the 
quality of patient care and lower health care spending.  One indicator of inadequate 
quality that results in increased healthcare spending is the rate of readmissions to a 
hospital. Recently hospitals became responsible for what happens to the patient up to 90 
days after discharge. Incentives in the form of payments and public recognition reward 
hospitals for reducing hospital readmissions. Starting in October 1st, 2012, the affordable 
Care Act (ACA) created new payment incentives with the Centers for Medicare and 
Medicaid Services’(CMS) Hospital Readmission Reduction Program (HRRP), which 
reduced payment to hospitals with higher-than-predicted risk adjusted readmission rates. 





hospitals that are providing primarily rehabilitation, psychiatric, long-term care, children 
care, critical care; also some cancer research centers are not included in this new 
payment policy ("Hospital Readmission Reduction Program," 2015). The HRRP policy 
exposes hospitals to financial risk with penalties that range from 1% to 3% of their 
aggregate payments in a single year based on their excess 30-day readmissions. A recent 
study of high-volume, urban tertiary orthopedic center has estimated that, their potential 
penalty from CMS could amount to over $6 million annually if their institution’s all-cause 
risk-adjusted 30-day readmission rates exceeded the national mean (R. Carter Clement et 
al., 2014). However, the method used by CMS to calculate excess readmission rates does 
not adjust for factors such as socioeconomic status, case mix, or patient’s admission or 
discharge disposition (to home vs, post-acute care facilities). HRRP targets acute care 
hospitals readmission rate within 30 days of discharge since this period is when 
discharged patients are most vulnerable to rehospitalization. Another payment model 
that imposes substantial financial risk at hospitals is the episode payment model such as 
Comprehensive Care for Joint Replacement Model (CJR) which holds hospitals financially 
responsible for the cost and quality of episodes of care delivered from the time of 
surgery through 90 days after discharge, thereby incentivizing increased care 
coordination between hospitals, physicians, and post-acute care providers. The model 
began on April 1, 2016 and will run through December 31, 2020. Policy makers are using 






 Since more risk has been shifted to hospitals, they have begun developing 
strategies such as: enhanced patient education, post-discharge follow-up care, and 
increased coordination with post-acute providers to reduce readmissions. Hospitals have 
adopted interventions involving patient care plans and post-acute care coordination, 
aiming to engage patients, family members, and caregivers in meeting patient needs 
after discharged from hospital, provide information needed to help avoid readmission, 
planning post-acute care, open communications channels, and other interventions to 
reduce the risk of unnecessary hospital readmission. Appendix C contains some of the 
interventions designed by hospitals that show favorable results in reducing hospital 
readmission rate. 
Studying risk factors associated with hospital readmissions, potential 
interventions, and related measurements is important to create effective programs that 
improve patient clinical outcomes, and design fair adjusted payment incentives that 
favorably affect healthcare cost and quality of care. Adjusting risk to account for patient 
characteristics, hospital factors, and post-acute care is essential for designing provider 
incentives that reduce hospital readmission and avoid unintended consequences. 
 
1.2    Joint Osteoarthritis.  
 
Osteoarthritis (OA) or degenerative joint disease is by far the most common form 
of arthritis which causes substantial physical and psychosocial disability in elderly 
population  (Gabriel & Michaud, 2009; Guccione et al., 1994; Salaffi, Carotti, Stancati, & 





conditions in the United States and estimated that approximately 27 million Americans 
aged 25 or older are affected by osteoarthritis, and the most commonly affected joints 
are knees, and  hips (Lawrence et al., 2008). According to the Arthritis Foundation 
webpage, one in two adults will develop symptoms of knee OA during their lifetime, and 
one in four adults will develop symptoms of hip OA by the age of 80 (Arthritis, 2017). And 
as the baby-boomer generation ages, the number of people with arthritis and rheumatic 
conditions in the United States is expected to reach 67 million by the 2030 (Hootman & 
Helmick, 2006). Osteoarthritis is progressive chronic condition in which cartilage ( the 
part that cushions the joint ) wears down ( Figure1.1) , and can lead to permanent 
functional disability, posing a serious health concern in affected patients ("Prevalence of 
disabilities and associated health conditions among adults—united states, 1999," 2001). 
 
     Figure 1.1 End-stage Osteoarthritis knee 
 
Currently, the process underlying osteoarthritis cannot be reversed, but 
symptoms can usually be effectively managed. A combination of weight control, 





(Macera, Hootman, & Sniezek, 2003). However, as osteoarthritis progresses, all joint 
structures will be affected, and conservative treatments might be ineffective to manage 
symptoms. In most cases, the best osteoarthritis treatment might be surgery to replace 
the affected joint, as the prosthetic implants, via the surgery, act as a substitute cushion 
for the damaged cartilage, thereby eliminating pain and restoring range of motion. Wide 
evidence indicates that, the majority of patients who have had a TJA procedure report 
improvement in pain and function (Callahan, Drake, Heck, & Dittus, 1994). A study by 
Hawker et al. estimated that 93.4% of all Medicare patients receiving knee replacements 
between 1985 and 1989 had a primary diagnosis of osteoarthritis (Hawker et al., 1998), 
which make Osteoarthritis the most common cause of TJA. The Agency for Healthcare 
Research and Quality (AHRQ) estimated that, $16.5 billion was spent in 2013 to treat 
patients with osteoarthritis, making osteoarthritis the second most expensive condition 
after Septicemia, accounting for about 4.3 percent of the aggregate costs for all 
hospitalizations is the U.S during the year of 2013.(Moore & Brian, 2016). 
 
1.3    Joint Arthroplasty. 
Total Joint Arthroplasty (TJA) is a common effective surgical procedure for end-
stage hip and knee osteoarthritis aiming to relieve pain and improve the patient’s joint 
function. During the procedure, surgeons cut away damaged bone and cartilage and 
replace them with an artificial joint made of metal alloys, high grade plastics and 





 Hip arthroplasty technique was developed by the British Orthopedic surgeon 
Johan Charnley in 1960, and twelve years later the first generation of knee total condylar 
prostheses was introduced in 1972 by Insall and colleagues (Gomez & Morcuende, 2005; 
Scuderi, Scott, & Tchejeyan, 2001). Joint replacement was widely performed in the 1970s 
and 80s, In the last few decades, major improvements in surgical materials and 
techniques have greatly increased its efficacy , and it is now generally considered to be a 
physically beneficial and cost-effective treatment for end-stage Joints arthritis (Pivec, 
Johnson, Mears, & Mont, 2012). 
 
 Several factors should be looked at before selecting a patient for joint 
arthroplasty, including age, comorbidities, and stage and anatomy of disease or joint 
damage. Contraindication for TJA may include active local or systemic infection, but other 
factors such as poor cardiovascular health , and neurological disease may also disqualify 
patient for TJA  ("NIH Consensus Statement on total knee replacement," 2003). 





Rehabilitation after TJA may take up to 12 months (Tribe et al., 2005), and 
outcomes after TJA varies according to patient demographics, health-related factors, and 
surgical factors (Parsons & Sonnabend, 2004). Reported rates of 30-day readmission 
rates after TJA have ranged from 4% to 8.5% based on the case complexity used to report 
these findings (K. J. Bozic et al., 2010; Cram et al., 2011). The vast majority of studies that 
investigate reasons for hospital readmission after TJA within 30-days of discharge have 
identified procedure-related complications such as infection, and dislocation of 
prosthetic joint to be the most common reasons for hospital readmission after TJA  
(Saucedo et al., 2014; Schairer, Vail, & Bozic, 2014). However, the quality and costs of 
care for hip and knee replacement surgeries vary greatly among providers. For instance, 
the rate of complications like infections or implant failures after surgery can be more 
than three times higher at some facilities than others. The cost of such procedures also 
varies; the average Medicare expenditure for the surgery, hospitalization, and recovery 
ranges from $16,500 to $33,000 across geographic areas (Cms.Gov, 2015). 
Previous studies on the risk factors for readmission after TJA rate have reported 
patient-related factors such as: age, gender (female), body weight (obesity), and higher 
than average patient’s length of hospital stay (LOS), to have a negative effect on the risk 
of 30-day readmission after TJA (Paxton et al., 2015).  In addition, multiple studies have 
found that, hospital-related factors such as hospital procedure volume and nonprofit 






 Recent improvements in TJA come from good understanding of the risk factors 
that influence readmission, and the need for a collaborative approach involving acute 
and post-acute care settings. The adoption of the quality initiatives such the ones that 
improve the transition between health care settings that enhance communication and 
patients’ education already demonstrated reproducibly excellent results in reducing 30-
day hospital readmission rate after TJA.  Appendix A contains some of the interventions 
designed by hospitals to reduce hospital readmission rate after TJA. 
 
1.4    Problem Statement. 
  
 Policy Interventions to lower hospital readmission and improve patient outcomes 
after TJA are constantly being introduced. In addition to the CMS HRRP that penalizes 
hospitals that have high TJA readmission rates, CMS announced new payment model, the 
Comprehensive Care for Joint Replacement (CJR) starting on April 1st, 2016 which enacts 
mandatory bundled payments for primary TJA in 67 geographic areas, where hospitals 
are held responsible for clinical outcomes and costs up to 90 days after surgery ensuring 
appropriate and high value post-acute care is more important than ever before. Previous 
studies on the effect of discharge destinations on the readmission rates after TJA were 
limited to patients discharged to inpatient rehabilitation sites such as skilled nurse 
facilities, or those discharged to home with care agencies; they did not address patients 
discharged to home without any form of post-acute care services. This lack of evidence is 
especially important in the case of the new bundled payments models that hold hospitals 





regardless of where the patient goes after care, placing increased emphasis on fast 
discharge of patients to the most appropriate destination, so they can minimize the use 
of unnecessary post-acute care services. Recently published work by Dundon et al, has 
demonstrated that, 20% decrease in the cost per episode of care, that was achieved by 
reducing discharge to inpatient rehabilitation from 44% to 28%, they also reported 
reduction on the 30-day readmission rate by 2% (Dundon et al., 2016). Our work will be 
using a large comprehensive dataset, the Nationwide Readmissions Database (NRD)  a 
unique and powerful database designed by H-CUP to support various types of analyses of 
national readmission rates for all payers and the uninsured, allowing us to follow TJA 
patients after hospital discharge, including those discharged to home with no aftercare 
services, so that, we will be able to investigate the effect of all possible discharge 
destinations on the readmission rate after joint replacement procedures. Sending TJA 
patients directly home without any further care might be an optimal cost saving option 
when it’s safe to do so. 
TJA readmission rate may also be affected by other factors which can be related 
to patient, hospital, and/or post-acute care settings. It is good to know how much each 
factor contributes to readmission risk. The availability of a large dataset that includes 
detailed patient and hospital information will allow us to achieve better understanding of 
factors that influence hospital readmission after TJA; most of the previous work is limited 
to single institution datasets or focus only on one payor group such Medicare patients. 





hospital readmission rate after TJA, would Medicare patients be at lower risk of hospital 
readmission considering the policy changes in last 4 years. 
 
1.5    Study purpose and Specific Aims. 
 
Unlike other available datasets, discharge destinations are defined 
comprehensively and clearly in our dataset including discharges to home without any 
further medical care. This dissertation explores the effect of all possible discharge 
dispositions (i.e.  direct to home, home with health services, and to post-hospital care 
settings) on the all-cause 30-day readmission rate after TJA procedures performed in the 
United State between January 1 and November 30, 2014. The theoretical motivation for 
this study follows the Donabedian model that provides a framework for examining health 
services utilization and evaluating quality of health care, incorporating some elements of 
the organizational design model  (Donabedian, 1966; Nadler, 1988). For our purposes, a 
key strength of the organizational design model is to acknowledge that, in order to be 
successful in reducing the readmission rate (better outcomes), the decision regarding 
discharge destination after TJA must be tailored to the patient’s needs and preference. 
The study takes a multidisciplinary approach to examine the effect of discharge 
dispositions on hospital readmission within 30 days of total joint replacement. Based on 
the results of this study, policy makers will better understand factors that may affect 
hospital readmission, so they can develop more fair and effective policies, or modify 
current policies to get patients the right care at the right time. Hospitals and caregivers 





a better understanding of what is a suitable destination after hospital care, so they can 
participate on their own care. A secondary goal of this work is to describe how patient 
characteristics, and hospital related factors affect 30-day all-cause readmission rate after 
TJA in the U.S in 2014. Three specific questions are asked, two of which are essentially 
descriptive queries and one are is an analytic question: 
1. Have there been differences in readmission rate between patients discharged 
direct to home without any form of post-acute care and those who received any 
type of post-acute care? 
2. Have there been differences in readmission rate between patients who 
received post-acute care services at home and those discharged to post-acute 
care facilities? 
3. what factors are associated with all-cause 30-day readmission rate after TJA in 
the United States in 2014? are there any differences in the TJA all-cause 30-day 
readmissions rate between payers? 
1.6. Relevance  
       The implementation of the prospective payment system under Medicare in 
1983 resulted in increased use of outpatient rehabilitation, as patients were being 
discharged earlier through the use post-acute care services as a mean to reduce acute 
care cost  (Kane, Chen, Blewett, & Sangl, 1996). Previous studies that investigate the 
effect of discharge disposition on patient outcomes after TJA have demonstrated no 





acute settings when compared to patients discharged to home, or to home with health 
services, after TJA (Chimenti & Ingersoll, 2007; Kelly & Ackerman, 1999; Tribe et al., 
2005). However, functional outcome studies on those works did not address the issue of 
postoperative complications that may have led to hospital readmissions. Buntin et al 
noted that patients who are discharged to a subacute setting after lower extremity joint 
arthroplasty have an 18% higher chance of either dying or going back to hospital within 
120 days of discharge (Melinda Beeuwkes Buntin et al., 2005). 
Some work has been done to address this concern, which demonstrated that,  
patients discharged home with health services had a significantly lower 30 day 
readmission rate compared to those discharged to inpatient rehab facilities (Ramos et al., 
2014). However, these findings cannot be generalizable to other institutions as they used 
their hospital database, while ours is a nationally representative data; also, they did not 
address patients who discharge to home without any form of post-acute care services. 
On a related note, Keswani et al, used the American College of Surgeons National Surgical 
Quality Improvement Program (ACS-NSQIP) database and reached the same finding, but 
they also couldn’t distinguish between patients who were sent home with health care 
services and those who were discharged to home with no further care  ( self-managed 
discharge destination)  as their data does not support such limitation (Keswani et al., 
2016).  This is especially important in the case of the new bundled payments models that 
held hospitals accountable for patient outcomes and cost of care up to 90 days of 
discharge, increased emphasis is placed on fast discharge of patients to the most 





services. Recently published work by Dundon et al, has demonstrated that, a 20% 
decrease on the cost per episode of care was achieved by reducing discharge to inpatient 
rehabilitation from 44% to 28%, they also reported reduction on the 30-day readmission 
rate by 2% (Dundon et al., 2016). A variety of nonclinical factors are likely affecting where 
patients go after hospital discharge.  Researchers  found a positive correlation between 
home health care use and the number of home health care agencies in an area (Kenney 
& Dubay, 1992). And another researcher has also found that, higher-income communities 
have higher utilization rates of post-acute care services (Neu et al., 1989). In the light of 
these findings, and the enactment of the bundled payments models, where the hospital 
is held responsible for clinical outcomes and costs up to 90 days after discharge, ensuring 
appropriate destination and high value post-acute care is more important than ever 
before. 
 A large, nationally representative sample of TJA patients that controls for a broad 
set of patient characteristics, hospital factors, and all possible discharge destinations 
including home with no rehabilitation, is needed to address the effect of discharge 
destinations on the readmission rate after TJA. This dissertation is using a large nationally 
representative dataset to compare 30-day readmission rate by discharge destination. A 
secondary focus is to identify patient, and hospital risk factors that contribute to all-cause 










   
 
2.1 Overview of Literature Review. 
 
The national health expenditure in the United States is expected to increase to 
USD 5.4 trillion by 2024, rising from 17.4 percent in 2013 to 19.6 percent of the gross 
domestic product in 2024 (Keehan et al., 2015). The latest national health expenditures 
report by CMS has estimated that hospital care accounts for 32 percent of the entire 
healthcare spending in 2016 (cms.gov, 2018). The Agency for Healthcare Research and 
Quality (AHRQ) estimates that hospital stays caused by musculoskeletal procedures are 
more expensive and longer than other hospitalizations and represent a significant portion 
of the total cost of hospital care. Hospitalizations involving musculoskeletal procedures 
particularly hip replacement, and  knee arthroplasty, cost about USD 20.1 billion in 
2014, accounting for 12.3 percent of aggregate costs for all inpatient stays (Elixhauser, 
William, & Anne, 2017). However, hospital readmissions after hip, and knee arthroplasty 
account for nearly 5% of the amount spent on TJA hospitalizations; Kurtz and colleagues 
estimated the economic burden of hospital readmissions up to 90 days after TJA at 





 The challenge with healthcare reform is to improve the quality of care without 
increase spending. One opportunity for reining in medical costs and improving quality is 
to reduce unnecessary expensive hospitalizations. 
 Recent improvements in hospital care have come from growing knowledge of 
factors that contribute to readmission. Throughout the literature, most of the studies on 
the rates and risk factors of TJA readmissions are on Medicare patients, or are comprised 
of small single institution samples. Medicare studies are restricted to patients aged 65 
years and older, while one-third of patients undergoing TJA are younger than 65 years 
and constitute the fastest growing group in the arthroplasty demand. (S. M. Kurtz et al., 
2009)   Single-center studies are undersized in their sample, lack the capability to capture 
readmission outside their specific hospital system, and produce results that are not 
generalizable to other hospital settings.  Also , previous studies focused on patients’ 
characteristics that contribute to rehospitalization within 30 or 90 days of the discharge, 
at a hospital level (V. Avram, D. Petruccelli, M. Winemaker, & J. de Beer, 2014; Cram et 
al., 2011; Cram et al., 2012; C. J. Lavernia & Villa, 2015; Pugely, Callaghan, Martin, Cram, 
& Gao, 2013). Other factors which relate to healthcare settings can, however, affect the 
readmission rate after total joint replacement; hospital ownership and teaching status 
have been found to negatively impact readmission rates after TJA (S. M. Kurtz et al., 
2016a). 
Therefore, investigating readmission risk factors for a large population of patients 





are needed that focus on care settings characteristics and the discharge destinations 
after TJA at the national level. Could there be an unwarranted assumption that discharge 
destinations contribute to any differences in the readmission rate in TJA? This research 
helps to fill the knowledge void by identifying and describing the readmission rate after 
TJA, and by evaluating factors for association with all-cause 30-day readmission rate after 
TJA in United States in 2014, using a nationally representative database that accounts for 
51% of total US hospitalizations. 
The Nationwide Readmissions Database (NRD) is part of the Healthcare Cost and 
Utilization Project (HCUP). Developed through a federal-state-industry partnership 
sponsored by the Agency for Healthcare Research and Quality. The NRD addresses a large 
gap in health care data: the lack of nationally representative information on hospital 
readmissions for all types of payers and the uninsured. The NRD is drawn from HCUP 
State Inpatient Databases program (SID) which contains reliable verified patient linkage 
numbers that can be used to track a patient across hospitals within a State, while 
adhering to strict privacy guidelines. The 2014 NRD is constructed from 22 SIDs. These 
states are geographically dispersed and account for 49.3 percent of the total U.S. 
resident population, and 51.2 percent of all U.S. hospitalizations. In fact, it is the only 
nationally representative database that is dedicated to the study of hospital 
readmissions, created to enable analyses of national readmission rates and to support 





2.2    Hospital Readmission. 
As described by the Centers for Medicare & Medicaid Services (CMS), hospital 
readmission is subsequent inpatient admission to any acute care facility that occurs 
within certain periods after the discharge date of an eligible index admission. The time 
periods are defined as long as 90 days of discharge, and includes hospital readmission to 
any acute hospital, not just the hospital at which the patient was originally hospitalized.  
The Agency for Healthcare Research and Quality as well as the Medicare program use an 
“all-cause” definition of readmission, which means any hospital stays within 30 or 90 days 
of a discharge from initial hospitalization are considered readmissions, regardless of the 
reason for the readmission. 
According to the CMS, historically about 19 % of total hospitalized Medicare 
patients were readmitted to the hospital within 30 days of their discharge. Prior to 2009, 
not much attention was paid to the hospital readmission rate. The Patient Protection and 
Affordable Care Act of 2010 included several initiatives in the form of payments and 
public recognition to provide incentive for hospitals to reduce hospital readmissions, 
aiming to improve health care quality. After being essentially unchanged from 2007 to 
2011, the 30-day all-cause hospital readmission rate among Medicare fee-for-service 
patients declined to 18.4 % in 2012. It was more than half percentage point lower than 
the average rate between 2007-2012 (Gerhardt et al., 2013). However, Medicare 
beneficiaries still are the highest in 30-day all-cause readmission rate compared with 
those who had Medicaid, private insurance, or uninsured individuals (Agency for 





all-cause readmission rate by expected payer from 2009 through 2013 created by the 
Healthcare Cost and Utilization Project (HCUP). 
 
 
Source: Agency for Healthcare Research and Quality (AHRQ) 
 
Figure 2.1  Rate of 30-day all-cause readmissions by expected payer, 2009–2013 
 
Hospital readmission following TJA hospitalization has increased in the last 15 
years. Cram and colleagues report an increase in 30-day all-cause readmission for 
Medicare population undergoing total hip arthroplasty from 5.9% to 8% between 1991 





readmission rates from 4.2% in 1991 to 5.0% in 2010 after knee arthroplasty (Cram et al., 
2012). In both of these studies Cram et al, report a change in patients’ discharge 
disposition over time with a decline in the use of hospital care and an increase in the use 
of post-acute care services. However, the rapid increase in Medicare post-acute care 
spending in the 1990s prompted passage of the Balanced Budget Act (BBA) of 1997 and 
implementation of a prospective payment system (shifting payments from a cost basis to 
prospective payment) for outpatient skilled care in 1998 and inpatient rehabilitation in 
2002 (Buntin, Colla, & Escarce, 2009; McCall, Korb, Petersons, & Moore, 2003).  The 
consequent result of those polices, was a decrease in the use of post-acute care and an 
increase in the percentage of patients being discharged home after TJA since 2004. Policy 
changes played a significant role in patients’ discharge disposition after TJA regardless of 
the effect on readmission rate. Knowing the effect of each discharge disposition on the 
readmission rate after TJA is essential to improving patient outcomes and lowing cost of 
care. 
In addition to the variation of readmission rate among payers, hospital 
readmission also varies by location within the U.S.  Kurtz et al. (2016) reported a 
significant degree of variation in the risk adjusted 30-day all-cause readmission rates 
after TJA in different areas of the U.S. As shown in (Figure 2.2) patients in the western 
states had the lowest 30-days readmission rates at 4.9%. Other census regions had 30-
day readmission rate of 6.0%-6.3%, rates 10% - 16% higher than in the Western region. 










Regional variation in avoidable readmission rates is an indication of inadequate 
quality of care, lack of appropriate coordination of post-discharge care, and inefficiency. 
In many cases the availability of post-acute care facilities is a major determinant of 
whether patients use such care after discharge from the hospital (M. B. Buntin et al., 
2005). Inadequate care transitions planning, bad communication, and delays in 
scheduling post care services are among the most common causes of preventable 
readmissions (Bisognano & Boutwell, 2009). When patients are discharge from hospital, 
they experience differences in healthcare services they receive from diverse post-acute 





care facilities such as Inpatient rehabilitations including skilled nursing setting, home 
healthcare, or home self-care. 
2.3    Economic Burden of Hospital Readmission. 
 
   Readmission has been a major challenge in the health-care system as it is costly 
and common among most patients discharged from acute care hospitals (Jencks, 
Williams, & Coleman, 2009). Hospital readmission has accounted for estimated annual 17 
billion dollars of unexpected cost for the federal government. Kurtz and colleagues 
estimated the economic burden of hospital readmissions after TJA at approximately USD 
1.1 billion on the U.S healthcare system in 2013 (S. M. Kurtz et al., 2017a). 
Bosco et al. (2014) studied readmission burden of TJA as a function of 
readmission rate, and they reported that , each 1.0 % increase in readmission rates 
following total hip arthroplasty results in an increase by 1.8% to the cost burden of these 
readmissions, and by 1.2 % to the cost burden after knee arthroplasty (Bosco, Karkenny, 
Hutzler, Slover, & Iorio, 2014). The Medicare Payment Advisory Commission (MedPAC) 
has estimated that 12% of readmissions are potentially avoidable. Preventing even 10% 
of these readmissions could save Medicare 1 billion dollars. 
 Increasing prevalence of TJA in recent years, has given more attention to hospital 
readmission following TJA, as it presents a large opportunity for cost saving and has 
therefore become a very popular target for bundled and fixed-cost programs by payers 





2.4    Studying Hospital Readmission. Why Is It Important? 
 
               Because of great developments in science, medicine, and technology, people’s 
life expectancy has risen from 47 to 73 years during the last 100 year (Gulland, 2014). By 
2050 the number of US adults aged 65 and older is estimated to increase to about 90 
million (twice the current number). As this number increases, the prevalence of chronic 
diseases associated with advancing age will increase too. Considering demographic and 
epidemiologic changes in American society, providing health care services for a high 
number of elderly individuals with co-morbidities will present great challenges. An 
increase in the elderly population generally leads to an increase in the demand for health 
care services particularly hospital beds. It has been predicted that by 2030 demands for 
primary hip arthroplasty will exceed 500,000 cases a year, and the demand for primary 
knee arthroplasty will reach nearly 3.5 million cases, 673 % higher than the number in 
2007 (S. Kurtz et al., 2007).  
Due to the rising demands resulting in pressure on hospital beds, the early 
discharge of patients from acute hospitals has been observed to lower the length of 
hospital stay from 9 days in 2000 to 4 days in 2013. The consequences of early discharges 
include high hospital readmission rates and lower inpatient quality of care. Cram et al. 
found that over the last 20 years, the hospital length of stay for TJA Medicare patients 
has steadily decreased over time with an increase in readmissions and increased 
discharges to post-acute care settings where patients can continue to receive the 
appropriate medical and rehabilitative therapy they require after discharge (Cram et al., 





regard to identifying the optimum setting where TJA patients should receive their care 
after hospital discharge. Also, one opportunity to reduce preventable readmission is to 
understand the factors that contribute to readmission. In a separate section of this study, 
some of the well-known factors that influence hospital readmission after TJA procedures 
will be discussed in more detail. 
 
2.5    Policy and Interventions to Decrease Hospital Readmission. 
 
At the end of the two-year national round table on Health Care Quality, all 
participants agreed on the lack of quality in the US healthcare system, both in the 
delivery of care and its financing mechanisms(Chassin & Galvin, 1998). Hospital 
readmissions are thought to be related to quality of care provided to the patient during 
the initial hospitalization. The wide variation in the hospital readmission rate across the 
country has supported this assumption, and consequently a proportion of hospital 
readmissions is avoidable (van Walraven, Bennett, Jennings, Austin, & Forster, 2011). 
Private payers and policy makers have highlighted the reduction of unnecessary 
hospitalization as a potential area for quality improvement and cost saving. They focused 
on a variety of initiatives in the form of payments and public recognition to reward 
hospitals that reduce the avoidable readmissions. 
 Hospital Readmissions Reduction Program(HRRP) requires the Centers for 
Medicare & Medicaid Services to reduce payments to hospitals if they have higher than 
expected risk-standardized 30-day readmission rates for TJA beginning in 2015 





the most important initiative in the effort to reduce hospital readmissions because it is 
difficult for hospitals to avoid. 
             Aligning health-care services’ payment with patients’ outcomes is a brilliant way 
to reform provider reimbursement. It is clear that, risk sharing strategies based on quality 
will likely be more common as the Federal government and other payers attempt to 
control costs without sacrificing quality. Payment mechanisms that promote a value-
based model (an outcome-based contract) instead of the previous purely quantity-based 
model of Fee for Services (FFS) such as bundled payments are being introduced (Sood et 
al., 2011). Where health care providers are held accountable for what happens to patient 
up to 90 days of the initial stay, increased emphasis is placed on discharge of patients to 
the most appropriate care setting after hospital stay if needed. 
Schneider & Mathios (2006) examined the differences in health care utilization 
across financial reimbursement arrangements using the principal Agency Theory, and 
they found that, contract designed payment is more efficient in controlling utilization 
when coupled with monitoring care services provided by the physician. From that point 
of view, the Agency Theory that explains that the relationship between principal and 
agent is driving this action (Schneider & Mathios, 2006), where the CMS is the principal 
and hospital are the agent. However, the new payment mechanism is not a fully 
outcome-based contract yet; it is a modified FFS, so the principal still needs to invest 
more in information to verify the agent’s behavior.  There is also the public reporting 





rates including TJA in 2015. And by doing that, policy makers are using a motivation tactic 
that has a combination of rewards and punishments to induce better performance. 
Public reporting of quality measures aims to increase transparency and 
accountability within the healthcare system. As a result, patients can make decisions 
about where to seek healthcare services (looking for the better contractor/seller). 
Hospitals and Post-acute care facilities will improve the quality of their services to get a 
better reputation in the market. The combination of public reporting and researchers’ 
growing interest in studying readmissions will increase transparency. Therefore, health 
care providers at all levels should consider a collaborative approach when delivering 
health services to eliminate unnecessary re-hospitalization and avoid the risk of losing 
revenue. 
 The Affordable Care Act called for public reporting of performance measures on 
quality, cost, and other metrics. The public reporting of 30-day risk-standardized 
readmission measures is consistent with the Institute for Healthcare Improvement (IHI) 
triple aim (Figure2.3). 
 
 






1. Improve health care quality. 
2. Improve the health of the US population. 
3. Reduce the costs of health care. 
Two federal agencies within the Department of Health and Human Services (HHS) 
are sharing the primary responsibility for the public reporting policy: The Agency for 
Healthcare Research and Quality (AHRQ), and the Centers for Medicare and Medicaid 
Services. AHRQ supports research, works with public and private stakeholders to develop 
quality measures, and reports aggregate national and state level data, while CMS collects 
data on performance measures and has developed a system to publicly report providers’ 
performance measures ("QualityNet - Readmission Measures," 2017). Unlike other 
initiatives, both public reporting and the Hospital Readmissions Reduction program are 
mandatory, and there is no chance for participant hospitals to opt out. 
The Partnership for Patients initiative was announced by the US Department of 
Health and Human Services on April 12, 2011. This five-year initiative aimed to improve 
the quality, safety, and affordability of healthcare. One of the PfP goals is to decrease 
hospital readmission by 20% by the end of 2013. ("Partnership for Patients | Center for 
Medicare & Medicaid Innovation," 2017). Three programs have been introduced to carry 
out initiative goals. 
 Hospital Improvement Innovation Networks, work at the regional, state, national 
and hospital system level to ensure continued harm reduction in the Medicare program, 
help to identify already proven solutions, and promote collaboration and teamwork 





4,000 hospitals across 16 Hospital Improvement Innovation Networks (HIINs) were 
participating in Partnership for Patients ("About the Partnership - Hospital Improvement 
Innovation Networks," 2017). 
The Centers for Medicare & Medicaid Services (CMS) has taken the next step in its 
mission to improve safety and reduce hospital readmissions for Medicare patients by 
awarding $347 million to those 16 health care organizations to serve as Hospital 
Improvement and Innovation Networks (HIIN). In October of 2016, CMS announced 
significant progress: an estimated 2.1 million fewer patients harmed, 87,000 lives saved 
and nearly $20 billion in cost savings from 2010 to 2014. CMS noted that efforts to 
address health equity for Medicare beneficiaries will be central to the HIINs’ goals (CMS, 
2016). 
Transitions from one setting to another, especially being discharged from a 
hospital to an acute care facility, are often dangerous points in health-care. Inadequate 
care transitions planning, bad communication , and delays in scheduling post-acute 
services are among the most common causes of preventable readmissions (Bisognano & 
Boutwell, 2009). The Community-based Care Transitions Program (CCTP) is another 
program by the partner for patient initiative mandated by Section 3026 of the Affordable 
Care Act; the CCTP provided a framework for community-based organizations (CBOs) to 
partner with hospitals to address the needs of high-risk Medicare fee-for-service (FFS) 
beneficiaries after hospital discharge. Safe, effective, and efficient care transitions 





post-acute care facilities. So, discharge destination after hospital stay has to be carefully 
chosen for vulnerable patients.  Under the CCTP program, the CMS announced funding 
opportunities with up to $300 million in total funding being available for 2011 through 
2015 for the acute-care hospitals that have high readmission rates to partner with 
community based organizations to provide care transition services aimed at improving a 
patient’s transition from a hospital to another setting, and assist with post discharge 
needs, ("Community-based Care Transitions Program | Center for Medicare & Medicaid 
Innovation," 2017). 
In a comparison study that investigated the effect of HRRP on hospital 
readmission rate , hospitals subject to penalties under the HRRP had greater reductions 
in readmission rate compared with non-penalized hospitals (Desai, Ross, Kwon, & et al., 
2016). Another study by Zuckerman et al (2016) investigated the effect of the HRRP on 
the readmission rate and found that risk-adjusted rates of readmission for conditions that 
were included in the HRRP policy have declined more rapidly than other conditions, 
where readmission for targeted conditions declined from 21.5% to 17.8%, and rates for 
non-targeted conditions declined from 15.3% to 13.1%. Trends in readmissions are 
shown in (Figure 2.4). TJA wasn’t included in the targeted conditions because it was 











The Military Health System (MHS) was one of the first organizations to participate 
in the Partnership for Patients initiative, by implementing the first enterprise-wide 
patient safety initiative in June 2011 and, by the end of 2013, a reduction of 11.1% in 
 
Targeted conditions were acute myocardial infarction, heart failure, and pneumonia. Points represent the 
mean rate weighted by the number of hospital index stays during the month. Solid lines represent the 
predicted rates. Slopes are the monthly change in the predicted rates, generated from a linear 
combination of regression coefficients. Models are adjusted for seasonality with the use of an indicator 
for each 3-month season for targeted and nontargeted conditions; seasonal indicators are set equal to 
their means to generate a smooth predicted line. October 2007 through March 2010 was the period 
before enactment of the Affordable Care Act (ACA); April 2010 through September 2012 was the period 
of implementation of the Hospital Readmissions Reduction Program, which set financial penalties for 
hospitals that had higher-than-expected readmission rates for targeted conditions; and October 2012 
through May 2015 was the long-term follow-up period after penalties were initiated. Dashed lines indicate 
divisions between periods. Source: (Zuckerman, Sheingold, Orav, Ruhter, & Epstein, 2016) 
 





readmissions rate was achieved, as compared to the baseline rate in 2010, avoiding 
nearly 500 harm events since PfP implementation; and achieving approximately $13.5 
million in cost avoidance (King et al., 2017). Where hospitals send patients makes a big 
difference in patient outcomes. The doctors have little official guidance or objective 
measurements to help them decide which patients will do best in each setting after 
hospital discharge, so measuring the effect of discharge destinations on the readmission 
rate is essential to develop such a tool, and the need for such a tool is more important 
than before as Medicare increasingly penalizes or financially rewards hospitals for 
reducing readmissions. 
 
2.5.1 Payment Reform Landscape. 
 
 In 2010, section 3021 of the ACA established the Center for Medicare and 
Medicaid Services Innovation Center (CMMSIC), whose objective was to develop and 
investigate alternative payment models for reimbursements to address both quality and 
efficiency of health care services. 
Another initiative that promotes coordinated and efficient care for TJA is the 
Bundled Payments for Care Improvement (BPCI) by the CMS Innovation Center, which 
has the potential to reduce expenditures while preserving or enhancing the quality of 
care for Medicare and Medicaid beneficiaries. Traditional Medicare payments pay 
providers separately for each of the individual services they provide to beneficiaries, 
which results in fragmented care with a low possibility of coordination across providers 
and health care settings (Stange, 2009). This new proposed approach is links payments 





method is expected to lead to higher quality and more coordinated care at a lower cost 
to Medicare. The goal for this initiative is to improve patient care and quality through 
increased care coordination supported by payment innovation. 
As shown in Table 2.1, The BPCI initiative is comprised of four broadly defined 
models of care with a prospective payment method that is designed to test whether 
linking payments for all providers involved in delivering an episode of care can reduce 
Medicare costs, while maintaining or improving quality of care. 
 
Table 2.1   Bundled Payments for Care Improvement Initiative Design . 
 
  Source: Centers for Medicare & Medicaid Services 
 
 
 Model 2 of the BPCI bundles is a retrospective payment that includes acute care 
hospital services expenses plus the post-acute care expenses, as well as all professional 
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services up to 90 days after hospital discharge. TJA, one of the targeted procedures, is 
the most common among all 48 clinical episodes included in this policy.("Medicare 
Program; Comprehensive Care for Joint Replacement Payment Model for Acute Care 
Hospitals Furnishing Lower Extremity Joint Replacement Services. Final rule," 2015). CMS 
launched the BPCI initiative under the authority of the Medicare and Medicaid Innovation 
Center. The goal of this initiative is to foster efficient collaborative care while reducing 
costs and protecting or improving the overall quality of care for patients who undergo 
TJA. 
 Hospitals, physician groups, post-acute care providers and other entities, entered 
in to agreements with CMS to be held accountable for total Medicare episode payments 
which are, expected to lead to higher quality and more coordinated care at a lower cost. 
However, episode-of-care payment for joint arthroplasty varies widely depending on 
patient’s health status, the procedure performed, and the readmission rate. Also, post-
discharge service expenses account for more than a third of total episode expenditures 
(K. J. Bozic, Ward, Vail, & Maze, 2014). Thus, reducing the readmission rate, and adjusting 
patient expectations for going home rather than to an inpatient facility are key factors to 
avoiding a financial burden, which align with the policy’s overall goal of reducing health 
care costs and increasing the value of the health care system. ( Figure 2.5) below is a 












Effective on January 15, 2016, the Comprehensive Care for Joint Replacement 
(CJR) model is an alternative payment model created for Medicare beneficiaries by CMS 
to support better and more efficient care for those patients undergoing inpatient hip and 
knee replacement surgeries. 
 For five years, this model will test bundled payment and quality measurement for 
episodes of care associated with hip and knee replacements to encourage hospitals, 





coordination of care from the initial hospitalization through recovery. CMS has 
implemented the CJR model in 67 geographic areas, including counties associated with a 
core urban area that has a population of at least 50,000; no urban core area with a 
population of less than 50,000 was eligible to participate. As of February 1, 2018, 
approximately 465 Inpatient Prospective Payment System (IPPS) hospitals in 67 different 
metropolitan statistical area (MSAs) are participating in this CJR model. 
The CJR program represents the efforts that CMS put into reforming payments 
under the value-based care model by 2018. Participants are encouraged to work closely 
with physicians and post-acute care facilities to reduce fragmentation of care, improve 
quality of care, and reduce costs. For the five years of the program,  CMS estimates a 
saving of $343 million,  which is expected to be from reduced readmissions and increased 
use of post-acute care, such as skilled nursing facilities(SNFs) ("Medicare Program; 
Comprehensive Care for Joint Replacement Payment Model for Acute Care Hospitals 
Furnishing Lower Extremity Joint Replacement Services. Final rule," 2015). 
 Figure 2.6 below is a pie chart created by a data analytics consulting company 
(Avalere) that illustrates payment allocation for an episode of care for a joint 
replacement procedure. They used a 100% of Medicare claims data to find out the 






Figure 2.6 Average Medicare Payment per CJR Episode, by Care Setting. 
 
Healthcare providers are concerned about the financial penalties and being held 
accountable by payers and policy makers for what happens to patients after being 
discharge from their facilities, wondering to what extent the gaps in performance for 
which they are being held responsible are actually under their supervision. Earlier work  
included 3282 hospitals across the country found that, large hospitals and teaching 
hospitals are more likely to be penalized than smaller, nonteaching hospitals (Joynt & Jha, 
2013), it is unclear why these hospitals have higher readmission penalty than others. 





patient medical comorbidities or socioeconomic status (Keeney et al., 2015). So, variation 
in readmission rates among hospitals may be driven by patient’s sociodemographic 
factors and does not have anything to do with hospital performance. 
Despite these criticisms of the new payment models, policy makers and 
healthcare providers share the belief that it is possible to better anticipate hospital 
readmissions and possible to avoid them. Healthcare providers have agreed that they 
play an important role in patients successfully transitioning from hospital to post-acute 
setting or to home. In January 2013, a large, tertiary, urban academic medical center 
started the Bundled Payments for Care Improvement (BPCI) initiative for TJA. They 
implemented the BPCI Model 2 for TJA in January 2013 and started the financial risk 
phase in October 2013. The Model 2 episode of care is a discounted retrospective form 
of payment from CMS that includes a 3-day hospital stay prior to the procedure, the 
inpatient, and post-acute care including procedural, physician, and all consultant fees and 
all costs through 90 days after the discharge. The final results show a 2% decrease in 30-
day readmissions compared to the baseline year, and a reduction of 0.62 day in length of 
stay compared to the baseline year for the targeted patient population. Another finding 
worth mentioning here is that post-acute discharge costs were lowered by decreasing 
the use of inpatient post-discharge care services; patients were encouraged to go home 
rather than to an inpatient facility (Dundon et al., 2016). The significant financial risk 
associated with reimbursement penalties have likely led to a variety of improvements in 
healthcare outcomes. However, further research is needed to investigate different 





access to care, and use of less expensive care settings such as acute hospitals, home 
health care, inpatient rehabilitations. Many factors must be examined to be able to 
obtain a comprehensive view of the 30-day readmission rate, including: the effect of 
patient characteristics; the effect of hospital characteristics, and the effect of after-
hospital discharge settings. This research may provide better insights into the current or 
future interventions to facilitate readmission risk adjustment methods that appropriately 
account for patient factors, and discharge destination after TJA. 
2.6   Risk Factors for Readmission. 
 
 Factors that influence the readmission rate can be thought of in three 
independent segments that relate to patients, delivery of care, and health care setting. 
Patient demographic factors that affect readmission rate such as age, gender, income, 
and payment source, as well as patients’ clinical factors such as severity of illness, Body 
Mass Index (BMI), and chronic illness, have been intensively studied over the last 15 
years. Providers’ performance and process of care have also been found to have a 
significant impact on the rate of hospital readmission (Bisognano & Boutwell, 2009).  
Additionally, care setting characteristics such as: ownership, teaching status, location, 
have also been studied to investigate the impact on the readmission rate among TJA 
patients(S. M. Kurtz et al., 2016b). 
An Individual’s characteristics are important factors in whether a patient will be 
readmitted to a hospital (AMA, 2011). Because of the increased association between 





question for health care providers is whether a patient’s age is associated with a greater 
risk of readmission. 
  There have been differing conclusions regarding the effect of age on the joint 
arthroplasty outcomes in the literature. In a recent cohort study of nearly 2000 patients 
who underwent primary TJA at a large academic medical center by Fang et al. (2015), 
outcomes where compared in patients stratified by age that was categorized by decade 
(≤50, 51-60, 61-70, 71-80, and ≥81). They found that, there was no statistically significant 
difference in all-cause 30-day readmissions between age groups. The result was 
supported by another cohort study of 502 patients older than 65 years who underwent 
TKAs or THAs in a large regional health system from January 2008 to September 2008 by 
Higuera et al. (2013): they did not find an association between age and the readmission 
rate during that period. However, in that same study, the authors concluded that, in 
terms of complications, patients were approximately 40% more likely to have at least one 
complication for every 10 years of age. 
  Despite these findings, there are substantial data that suggest that a patient’s age 
is a predictor of hospital readmission. Jauregui et al. (2015) compared outcomes 
including readmission rate of TJA between patients <90 years of age vs. >90 years. They 
found that the nonagenarians group had higher readmission rate than the control group 
(6.9% vs. 3.8%; P = 0.005). This is consistent with the finding of Miric et al. (2014), who 
reported a statistically significant difference in the readmission rate among their study 
groups, with the rate among nonagenarians nearly tripling the rate seen in patients 





above have reported an increase in the use of post-care services among older patients 
compared with middle and younger age groups, which might be related to the overall 
health status of older patients, including their physical capability after such major 
surgery. 
 Readmission rates vary across patients’ sex, with females having a slightly higher 
readmission rate (59%) than male patients (41%) (Victoria Avram, Danielle Petruccelli, 
Mitch Winemaker, & Justin de Beer, 2014). S. M. Kurtz et al. (2016a), who studied 
readmission after total hip arthroplasty using 100% Medicare data set (2010-2013) also 
found the same results, where female patients had a higher readmission rate than men 
with a difference of 20% between the two gender groups. 
 In addition to age and gender, personal economic status has also been recognized 
as a factor that influences hospital readmission after joint arthroplasty. Oronce et al. 
(2015) utilized the California State Inpatient Database (SID) to study the association 
between the incidence of unplanned readmission and patient socioeconomic status. They 
found that, patients living in high-poverty neighborhoods were 24% more likely than 
others to be readmitted (OR= 1.24; 95% CI, 1.10–1.39). Furthermore, in that same study 
authors discovered that, Medicaid patients had a readmissions rate that was 6.8% higher 
than privately insured patients. Mesko et al. (2014), who studied demographic factors 
associated with readmission after primary TJA, also found that the insurance payer is the 
only factor that shows an independent association with readmission, where government 
insured (Medicare/Medicaid) patients comprise the highest proportion of patients 





factors, it is worth paying attention to how much patient clinical factors such as weight, 
severity of illness, and the existence of chronic condition impact the readmission rate 
after TJA. 
The National Health and Nutrition Examination Survey of 2007-2008 reported a 
substantial increase in obesity within the United States population (Flegal, Carroll, Ogden, 
& Curtin, 2010). Obesity is widely acknowledged as a risk factor for both the incidence 
and progression of joint disease (Anandacoomarasamy, Fransen, & March, 2009). In a 
systematic literature search by Blagojevic et al. (2010), the pooled odds ratio for 
developing knee osteoarthritis was 2.63 times CI (2.28-3.05) greater for obese patients 
compared to normal-weight patients. Lementowski and Zelicof (2008) reported a 36% 
increased chance of developing degenerative joint disease for every 2-unit (5 kg) increase 
in body mass index. Considering that, the prevalence of obesity is not expected to change 
(Flegal, Carroll, Kit, & Ogden, 2012), defining the relationship between obesity and 
arthroplasty outcomes become increasingly important. In a recent published study by 
Chen et al. (2016), the relation between Body Mass Index and 30-day readmission is 
positively correlated, where the risk of getting readmitted increases as the BMI increases. 
Beside the risk of readmission, a study examined obesity’s impacts on the other 
outcomes found a negative impact of obesity on patients’ clinical function and patients’ 
satisfaction after TJA  (Järvenpää, Kettunen, Soininvaara, Miettinen, & Kröger, 2012). 






Hospital-related variables associated with readmission risk after joint arthroplasty 
have been previously studied by Kurtz, Lau et al , who used Medicare 100% national 
hospital claims data and found that , Hospital  procedure volume, rural hospital location, 
and hospital ownership were the only significant hospital factors that were associated 
with the risk of 30-day readmission after total knee arthroplasty (S. M. Kurtz et al., 
2016b). 
 
2.7    Use of Total Joint Arthroplasty Readmission as Quality Metric. 
 The primary treatment goal of TJA is the restoration of independence in the 
activities of daily life by reduction of pain and disability, so in such surgery, the most 
direct measures of quality are outcome measures, because assessing pain, functional 
status, and quality of life before and after surgery can be easily measured (Brady, Masri, 
Garbuz, & Duncan, 2000). In a study by Harvard School of Public Health, that studied 30 
day hospital readmission after six major surgeries including total hip replacement 
procedure found that, surgical-readmission is associated with surgical quality , given the 
policymaker the confidence to use surgical readmission rates to rank and pay hospitals 
(Tsai , Joynt , Orav , Gawande , & Jha 2013). 
The readmission rate within 30-days of discharge has been used as a hospital 
quality measure for a long time (Ashton & Wray, 1996; Vorhies, Wang, Herndon, 
Maloney, & Huddleston, 2011) ,  and it has become a well-known cost efficiency metric 
for policy makers (Adelani, Keeney, Nunley, Clohisy, & Barrack, 2013; Rutledge Carter 





care services has been reported in numerous studies (Ramos et al., 2014). In a study that 
investigated the validity of the readmission rate as a routine indicator of the quality of 
hospital care, the authors concluded that “adjusted rates of potentially avoidable 
readmissions are scientifically sound enough to warrant their inclusion in hospital quality 
surveillance” (Halfon et al., 2006). In the interest of promoting high-quality, patient-
centered care and accountability, CMS has identified hospital-level 30-day risk-
standardized readmission rates following an elective primary total joint replacement as a 
quality outcome for US acute hospitals, assuming that great clinical variation among US 
hospitals represents an opportunity to improve both quality of care and the cost 
effectiveness of services provided ("QualityNet - Measures," 2018) 
While outcome measures including readmission may seem to represent the “gold 
standard” in measuring hospital quality, the use of inadequately adjusted rates may lead 
to inappropriate conclusions regarding a hospital’s quality. Several problems with the use 
of readmission rate as a quality metric have been noted, including the effects of variables 
outside of a hospital’s control such as patient and community related factors. Thus, risk-
adjustment methods that correct for differing characteristics within a population, such as 
patient severity of illness can help account for some of these factors (Carlos J. Lavernia, 
Laoruengthana, Contreras, & Rossi, 2009). 
However, the use of alternative care settings after discharge from an acute 
hospital, such as short-stay hospital, outpatient observation status, and other types of 
outpatient care facilities, may influence the readmission rate, undermining the use of the 





clinically adequate, and a more cost-efficient alternative compared to the expensive 
acute care settings. Therefore, the influence of post-acute care settings on the 
readmission rate should be evaluated to determine whether quality interventions are the 
main driver of change in the readmission rate. 
 
2.8    Incorporating Severity of Illness and Comorbidity in TJA. 
The characteristics of patients who qualify for TJA vary. Some patients are 
relatively young and healthy, whereas others are old and suffer from several comorbid 
diseases that are not related to the principal diagnosis. Researchers have found that, 
medical co-morbidities contribute to hospital readmissions and in some cases to 
reoperations which increases the cost and the consumption of healthcare 
resources.(Olthof, Stevens, Bulstra, & van den Akker-Scheek, 2014). Therefore , there is a 
need for a classification tool to assess patient comorbidities prior to the medical 
intervention because they may delay diagnosis, alter treatment ,or even affect the 
analysis when measuring patient outcomes (Feinstein, 1970). 
The American Society of Anesthesiologist physical status classification system 
(ASA) is a risk stratification tool that is used to classify patients based on their pre-
operative medical status. Schaeffer and colleagues examined the correlation between 
ASA score and readmission rates in TJA patients. They find that patients with an ASA 






However, hospital administrative data have been widely used for examining 
issues related to payment, cost, utilization, and patient outcomes. All these topics require 
adjustment for patient severity of illness. Researchers can develop their own methods or 
select one of the severity measurement systems available in the public or private domain. 
The All Patients Refined Diagnosis Related Groups Severity of Illness levels (APR DRG-
severity) is another widely used classification system to address patients’ severity of 
illness ("Healthcare Cost and Utilization Project (HCUP) NRD Notes," 2018). Amit et al, 
found that, the APR-DRG severity-of-illness classification is a useful tool for planning 
tailored, cost-effective patient care preoperatively in joint arthroplasty (Shah, Vail, Taylor, 
& Pietrobon, 2004). Bozic et al , also found that, the APR-DRGs severity  was predictive of 
hospital costs in patients receiving TJA (Kevin J. Bozic, Rubash, Sculco, & Berry, 2008). The 
Agency for Healthcare Research and Quality has selected the APR-DRG system to be used 
as a severity-adjustment tool, and to be included in the latest refinement of the 
Healthcare Cost and Utilization Project Quality Indicators.("Healthcare Cost and 
Utilization Project (HCUP) NRD Notes," 2018). 
 
2.9    Use of Healthcare Cost and Utilization (HCUP) Dataset. 
Patient privacy regulations and the lack of reliable patient identifiers that enable 
the tracking of patients in hospital administrative data were obstacles in pursuing 
readmission studies at the national level. But the Agency for Healthcare Research and 
Quality's (AHRQ) released a new large administrative inpatient dataset in November 2016 





various types of analyses of national readmission rates for all payers and the uninsured. 
The NRD is drawn from HCUP State Inpatient Databases (SID) containing verified patient 
linkage numbers that can be used to track a person across hospitals within a state, while 
adhering to strict privacy guidelines. Unweighted, the NRD contains data from 
approximately 15 million discharges in 2014. Weighted, it estimates roughly 35 million 
discharges in the United States. Using such data is a key factor to understanding the 
effects that discharge destination and hospitals’ discharge volume have on the 
probability of hospital readmission at the national level. Since this dataset accounts for 
51.2 percent of the total U.S. resident population and 49.3 percent of all U.S. 
hospitalizations, perhaps this study’s greatest utility lies in the validation and 
comprehensiveness of this dataset. 
 
2.10 Summary of Literature.  
 Articles relevant to this work have been identified using a MEDLINE database 
search. We performed a search using the terms: on rehospitalization, readmission, Total 
Joint Arthroplasty, joint replacement, knee replacement, hip replacement, and care 
transitions. We used a combination of these terms, performing a Medical Subject 
Heading (MeSH) search in PubMed. We limited our search period from January 2005 to 
January 2017 and only included English language studies, and human studies. Additional 
articles and policy briefs were used, such as the ones that were recommended by AHRQ, 





 Previous studies that investigated the effect of discharge disposition on patient 
outcomes after TJA were limited but have demonstrated no significant difference in the 
overall functional outcomes of patients discharged to post-acute settings when 
compared to patients discharged to home, or to home with health services after TJA 
(Chimenti & Ingersoll, 2007; Kelly & Ackerman, 1999; Tribe et al., 2005). However, 
functional outcome studies did not address the issue of postoperative complications that 
may lead to hospital readmissions; hospital readmission rate also was not reported in 
these works. Buntin et al noted that patients who are discharged to a subacute setting 
after lower extremity joint arthroplasty have an 18% higher chance of being either dead 
or going back to hospital within 120 days of discharge(Melinda Beeuwkes Buntin et al., 
2005). Some work has been done to address this concern, which demonstrated that 
patients discharged home with health services had a significantly lower 30 day 
readmission rate compared to those discharged to inpatient rehab facilities (Ramos et al., 
2014). Furthermore, these findings cannot be generalized to other institutions as they 
used a single hospital database; also, they did not address patients discharge to home 
without any form of post-acute care services. On a related note, Keswani et al, used the 
American College of Surgeons National Surgical Quality Improvement Program (ACS-
NSQIP) database and reached the same result, but they also couldn’t distinguish between 
patients who sent home with health care services and those who discharge to home with 
no further care  ( self-managed discharge destination) (Keswani et al., 2016). This is 
especially important in the case of the new bundled payments models that hold hospitals 





increased emphasis is placed on fast discharge of patients to the most appropriate 
destination, so they can minimize the use of unnecessary post-acute care services. 
Recently published work by Dundon et al, has demonstrated a 20% decrease on the cost 
per episode of care that was achieved by reducing discharge to inpatient rehabilitation 
from 44% to 28%; they also reported reduction on the 30-day readmission rate by 2% 
(Dundon et al., 2016). 
 A variety of nonclinical factors are likely affecting where patients go after hospital 
discharge. Researchers found higher-income communities have higher utilization rates of 
post-acute care services (Neu et al., 1989), so patient’s type or lack of insurance plays a 
role where patients go after hospital care.  In the light of these findings, and the 
enactment of the new bundled payments models, where the hospital is held responsible 
for clinical outcomes and costs up to 90 days after discharge, ensuring appropriate 
destination and high value post-acute care is more important than ever before. 
In order for hospitals and other caregivers to provide the best possible care 
services to their TJA patients, they need to know where to send their patients after 
discharge; also patients need to have reliable and understandable information in order to 
participate on that decision. 
A large nationally representative sample of TJA patients that controls for a broad 
set of patient characteristics, hospital factors, and all possible discharge destinations 
including home with no further rehabilitation is needed to assess the effect of all possible 
discharge destinations on the readmission rate after TJA. To fill that void, this dissertation 





representative dataset to compare 30-day readmission rate by discharge destinations 
after TJA. A secondary focus is to identify patient, and hospital risk factors that contribute 





























3.1   Study Design 
  The study design is a secondary analysis of longitudinal data on TJA patients and 
their hospitalizations over a 30-day period following the index admission. Studying 
patients that repeatedly use or cross between health care settings such as hospital 
inpatient, and post-acute care, is difficult for many reasons, including a lack of patient 
identification number that enable tracking of patients in hospital administrative data, as 
well as privacy concerns. We are utilizing a recently developed nationwide readmission 
database from the Healthcare Cost and Utilization Project, which contains verified patient 
linkage numbers that can be used to track a patient across care settings within a state, 
while adhering to strict privacy guidelines. 
The hospitals included in the database are community hospitals, defined as short-
term, non-federal, general, public, academic, or other hospitals, excluding hospital units 
of other institution; our data include 2048 community hospitals in 22 states. HCUP data 
excludes rehabilitation and long-term acute care hospitals. Veterans Hospitals and other 
federal hospitals are also excluded (2014 Agency for Healthcare Research and Quality, 
2018a). The dataset excludes patients with missing or questionable patient linkage 





their total discharges were entirely excluded, because patients treated at these hospitals 
may not be reliably tracked over time. 
 Our study’s focus is the inpatient index hospitalization and all-cause 30-day 
readmissions, hospital and patient characteristics, primary diagnosis, severity of illness, 
and patient discharge disposition. TJA readmissions could occur for any reason at the 
same or a different hospital during the study time period. Transfer on the same day does 
not count as readmission, if a patient was transferred to a different hospital on the same 
day or was transferred within the same hospital the two events are only counted once, 
and the second event was not counted as a readmission. Every qualifying hospital stay is 
considered as a separate index admission, so one patient can have multiple index 
admissions regardless of how far apart they occur during the study period. Also, an index 
admission does not require a prior “clean period” with no hospital stay, that is, a hospital 
stay may be a readmission for prior stay and an index admission for a subsequent 
readmission. Admissions were disqualified as index admission if they could not be 
followed for 30 days. 
 Qualifying index event criteria was an adult discharged alive after Total Knee/Hip 
replacement procedure. Every qualifying hospital stay is counted as a separate index 
admission, which is the starting point for follow-up to check for readmissions. Thus, a 
single patient can be counted multiple times and can have multiple index stays during the 
observation period (January 1st to November 30th). The readmission is subsequent 
hospital admission in the same or a different hospital within 30-day of the original 





followed from January to November which allowed a 30-day window from each index 
event to find out the readmission cases.  
Readmission rate will be calculated as, number of TJA stays with at least one 
readmission stay for any reason within a month of previous discharge, divided by the 
number of stays with an admission for TJA in first 11 months of 2014. This approach may 
count a readmission in January as an index event, as the data from December of previous 
year is not available, Also the approach used to calculate readmission rate in this study is 
different than the one used  by CMS to calculate readmissions rate following elective 
total hip and/or knee arthroplasty; the CMS formula for readmission rate is computed 
using a three-year rolling period of measurement of computed excess readmission over 
expected that is different than the one used in this work . See Appendix A for more 
details on the approach used in this study. 
 Patient's disposition, defined as the consequent arrangement or event ending a 
patient's encounter in the reporting facility. To make codding uniform across HCUP data 
sources, the variable (DISPUNIFORM) combines detailed categories in the more general 
groups including: (1) Routine discharge , which mean discharged to home or self-care; (2) 
Transfer to short-term hospital; (5) Transfer to Skilled Nursing Facility (SNF), Intermediate 
Care Facility (ICF), and another type of facility; (6) Transfers to Home Health Care, under 
care of organized home health service organization in anticipation of covered skilled care; 





American Hospital Association (AHA) Annual Survey of Hospitals will be used to 
identify hospital characteristics such as ownership, number of beds, teaching status, and 
urban-rural location. 
 The study population will be risk-adjusted using the severity level variable (APR-
DRGs) four categories of severity of illness which been developed to reflect the clinical 
complexity of the patient population. The APR-DRG SOI determines the extent of system 
breakdown or organ dysfunction. There are 4 levels of the SOI subclass ranging from 1 to 
4. A higher number indicates multiple, serious diseases, and associated interaction. 
 Patient characteristics, hospital characteristics, payer characteristics, and 
discharge disposition have been categorized. The time frame of this study included any 
total joint arthroplasties, Knee or Hip between January 1st and November 30th, of 2014. 
3.2 Data Sources. 
3.2.1 Overview of the NRD. 
 
 The NRD is the only nationally representative database that is dedicated to the 
study of hospital readmissions, created to enable analyses of national readmission rates 
and to support public health professionals, administrators, policymakers, in their decision 
making. The Nationwide Readmissions Database (NRD) is part of the Healthcare Cost and 
Utilization Project (HCUP) database. Developed through a federal-state-industry 
partnership sponsored by the Agency for Healthcare Research and Quality, the NRD 
addresses a large gap in health care data, the lack of nationally representative 
information on hospital readmissions for all types of payers and the uninsured. The NRD 





verified patient linkage numbers that can be used to track a patient across hospitals 
within a State, while adhering to strict privacy guidelines. The 2014 NRD is constructed 
from 22 SID. These states are geographically dispersed and account for 49.3 percent of 
the total U.S. resident population, and 51.2 percent of all U.S. hospitalizations. Appendix 
B, (Table1) identifies the statewide data organizations that contribute to the NRD. For 
information on the geographic distribution of the 22 HCUP Partner organizations 
participating in the 2014 NRD see Appendix B (Figure1). 
The NRD is limited to data from community hospitals that are not rehabilitation or 
LTAC facilities. Non-community hospitals were excluded because of inconsistent capture 
of data across HCUP States. Rehabilitation or LTAC hospitals were excluded because they 
treat a unique patient population that has longer stays and higher costs. Information on 
the percentage of SID discharges excluded by type of exclusion provided in the Appendix 
B, (Table2). Details on the number of hospitals in the NRD are provided in Appendix B, 
(Table3). 
After exclusions, the 2014 NRD contains about 85 percent of total SID discharges 
from the participating states. Unweighted, the NRD contains approximately 15 million 
discharges in 2014. The HCUP calculated discharge weights for each NRD record based on 
the patient and hospital stratum in the SID data to represent roughly 36 million discharges 
in the United States. 
   
3.2.2 Data Structure  
 





• Discharge-level files 
• Core File: Contains data elements critical to readmission analyses. 
• Severity file: Contains additional data elements to aid in identifying the severity of 
the condition for a specific discharge (e.g., comorbidity flags, 3M All-Patient 
Refined Diagnosis-Related Group [APR-DRG] value, risk of mortality, and severity). 
• Diagnosis and Procedure Groups File: Contains additional information on the 
diagnoses (e.g., chronic condition indicators) and procedures (e.g. procedure 
class). 
• Hospital-level File: Contains information on hospital characteristics. 
The four files were opened, sorted, and merged by unique record identifier (KEY_NRD) 
using STATA’s command (merge) to create a master file to be used in this study. 
 
3.3   Study Population 
 The study population is all adult patients who underwent a primary Total Joint 
Arthroplasty in 2014, who were discharged alive from community hospitals, excluding 
rehabilitation or long-term acute care hospitals, from 22 participating partner states from 
all regions of the United State and account for 49.3 of the total US resident population 
and 51.2 of all US hospitalizations. 
 Out of state residents were excluded because the HCUP patient linkage numbers 
only can follow a patient within a state. Total joint arthroplasty discharges were identified 





 3.3.1   Exclusion Criteria 
 In addition to the NRD data exclusions in APPENDIX A Table2, Exclusion criteria for 
admission and readmission in this study are illustrated in table3 below. 
Table 3.1 Study Exclusion Criteria. 
Out of state residents were excluded because the HCUP patient linkage numbers   
only can follow a patient within a State. 
Patients who died while inpatient during the index hospitalization (because there 
was no chance for readmission. 
Patient with missing (NRD_Days ToEvent) the admission date or missing (LOS) 
length of stay also were excluded, because both are important to calculate time 
between admissions.  
Patients who were discharge against medical advice; because patient will not have 
the opportunity to receive full medical care that he/she need prior to the 
discharge. 
 




3.4 Measurement of Variables 
 
3.4.1 Primary outcome Measure 
 For each hypothesis tested in this study, the primary outcome was the presence 





Patients undergoing primary THA and TKA were identified in the NRD using International 
Classification of 
Diseases, 9th Revision, Clinical Modification (ICD-9-CM) procedure codes 81.51 and 
81.54, respectively, while readmission can be any reason within 30-days of the index 
discharge date.  
The Healthcare Cost and Utilization Project provide step by step online tutorial 
that explains how to use the Nationwide Readmissions Database, or NRD, to produce 
national estimates of inpatient readmissions for any condition (Tutorial, 2018). 
Three HCUP data elements are critical to tracking a patient and determining the 
time between admissions: NRD_VisitLink, NRD_DaysToEvent, and LOS (length of stay). 
Patient Linkage Number (NRD_VisitLink). 
NRD_VisitLink is the data element that links for all inpatient stays associated with a 
unique patient. All discharges in the NRD include a value for NRD_VisitLink. The value was 
assigned based on a unique combination of the synthetic patient linkage number 
provided by the HCUP Partner, date of birth, and sex. No verified patient linkage number 
was assigned if any one of the three pieces of information was missing.  
 
NRD_DaysToEvent, and (LOS) length of stay. 
Randomly-assigned start date, NRD_DaysToEvent is used instead of actual admission and 
discharge dates in order to comply with privacy guidelines, and it is used with the Length 






Time Between Admissions  
In order to calculate time between admissions in this study, I used the variables 
NRD_ Days_ToEvent (fake starting date) and LOS (length of hospitalization) to create new 
variable called DischargeDate ( fake discharge date )  
DischargeDate =  NRD_ DaysToEvent + LOS 
Example: to identify readmission stays. 
A patient has a 3-day hospital admission on 1/10/2014 and another admission on 
1/25/2014. 
• Based on the randomly-assigned start date for the NRD_VisitLink, the 
NRD_DaysToEvent value is 1009 for the 1/10/2014 admission. And the 
NRD_DaysToEvent value is 1024 for the 1/25/2014 visit. 
Discharge date for the first stay will calculated as = 1009 ( NRD_DaysToEvent) + 3 ( LOS ) = 
1012. 
Determining the number of days between the end of first admission and the start of the 
second admission will be as below: 
Second Stay (NRD_DayToEvent) 1024 –  Previous DischargeDate 1012 = 12 days between 
the two events. 
According to our readmission’s criteria in this study, an index admission will be counted 
as a readmission if it happened (NRD_ Days_ToEvent ) within 30 days of the initial stay 
(DischargeDate), other than that it will be count as new index admission. 





3.5 Analytical Methods by Research Aims. 
 
3.5.1 Aim 1: Differences in readmission rate based on discharge destinations.  
 
 Have there been differences in readmission rate between patients who discharged direct 
to home without any form of post-acute care and those who received any type of post-
acute care, or there been differences in readmission rate between patients who received 
post-acute care services at home and those who discharged to post-acute care facilities 
 
 Hypothesis#1 : Patients who received any form of post-acute care services are less 
like to be readmitted to a hospital within 30 day of discharge after TJA. 
 Hypothesis#2 : Patients who received post-acute care services at home are less 
likely to be readmitted to hospital within 30-day of discharge after TJA. 
Patients will be grouped according to their discharge destination into one of three 
scenarios: 
• Home (Direct to home without Home Care Servicers). 
• Home with Health Services. 
• Inpatient rehabilitation including Skilled Nursing Facility (SNF). 
• Descriptive statistics will be performed, and 30-day readmission rates will be 
compared between discharge dispositions using the Chi-Square test. 
3.5.2   Aim 2: Patient, and hospital factors associated with the30-day readmission after 
TJA. 
 
What patient, and hospital factors are associated with the30-day readmission after TJA, 





• logistic regression analysis will be performed to evaluate factors associated with 
30-day readmission while controlling for age, gender, and severity of illness. 
Factors investigated will include hospital related, and patient related factors.  
 
 
logit  (p) = b0 + b1 X1 + b2 X2 + b3 X3 
 
 
where P is the probability of being readmitted, the logit transformation is defined as the 
logged odds: 
 
   and  
 
 
X1 = Patient Characteristics 
X2 = Hospital Characteristics 
X3 = Discharge dispositions 
 
Models include hospital characteristics, patient characteristics, and post-hospital care 
characteristics, to determine whether they influence the results. Age will be analyzed by 
age groups (under 45 years old, 45-54 years old, 55-64 years old, 65-74 years old, 75-84 
years old, and 85 or more years). Age was of particular interest as recent literature 
suggests that total joint procedures are becoming more commonly used in younger 
adults than was typical until the end of the 20th century. To consider significant 
association, P-value must be less than 0.0001. 
 
3.6   Covariates. 
 As suggested in the introduction section of this study, the variables of interest for 





characteristics. We used the discharge-level files to obtain patient related variables 
including information on the procedure performed, and the severity level. Hospital-
related variables associated with readmission risk have been previously studied by Kurtz, 
Lau et al (S. M. Kurtz et al., 2016b). Hospital-level file provided by the American Hospital 
Association (AHA) were used to obtain information on hospital characteristics. 
Hospital administrative data have been widely used for examining health care 
utilization, and patient outcomes. Both require adjustment for patient severity of illness. 
Researchers can develop their own methods or select one of the severity measurement 
systems available in the public or private domain. In this study we are utilizing the 
severity of illness index ( APR-DGRs- Severity) as a severity adjustment tool because, it is 
the most applicable to the HCUP inpatient databases (2018 Agency for Healthcare 
Research and Quality, 2018). Table 3.2 below provides a summary of All Covariate 
variables in this study. 
 





Post-Hospital Care Variables 
 
Hospital variables  
 
1. Age (AGE)                    
Continuous  
2. Sex (FEMALE)             
Categorical 
3. Primary Payer  (PAY1)                      
Categorical 
5. Severity level  
(APRDRG-Severity)  
Categorical 
      
  1. Disposition of Patient               
        (DISPUIFORM) 
            Categorical 
 
1. Hospital Ownership 
(H_CONTTRL) 
          Categorical 
 
2. Bed size of hospital  
 (HOSP_BEDSIZE) 





3.7    Descriptive Statistics. 
 A total of 1,093,272 TJA admissions in 2014 were identified using (ICD-9-CM) 
Procedure codes 81.51 Total Hip Arthroplasty for and 81.54 for Total Knee Arthroplasty. 
The average length of hospital stay for these admissions were 3.16 days. And the median 
age for TJA patients was 65 years. Pie charts below created using Stata 15.1 illustrate 
admissions’ basic statistic related to the primary payer, discharge destinations, as well as 




                  Figure 3.1  Discharge disposition after TJA. 
 
The most common discharge disposition after Total Joint Arthroplasty procedures 
was to home with home health agency services (44.9%), 26.1% were discharged to Skilled 








Fifty-fife (55%) percent of TJA patients have Medicare as their primary insurance, 
36.7 % have Private insurance as their primary insurer, and 4.1% have Medicaid, and 3.4 
had Other. 
Figure 3.2  Expected Primary Payer for Total Joint Arthroplasty 





75.7% of total discharges where discharged from private not for profit hospitals, 
14.3% were discharged from proprietary hospitals, and 10 % where discharges from 
nonfederal government hospitals. 
 
 
                         Figure 3.4 Discharges by hospital's Bed Size. 
 
 
48.3 % of total discharges where discharged from large hospitals, 30.5 % were 
discharged from medium size hospitals, and 21 % where discharges from small size 
hospitals. 
 
3.8   Data Management and Quality Assurance. 
All users of HCUP data must complete the HCUP Data Use Agreement (DUA) 
Training Course and sign an HCUP DUA before receipt or use the data. A web-based 
training course was taken to achieve certification as required by the AHRQ. All 





secure storage and data access as well as privacy protection of data elements including 
patient identifiable information, or hospitals specific information. 
After loading the data according to the HCUP guidelines, data were verified by 
reviewing the frequency of TJA procedures in 2014 summary statistics reports provided 
by the data website and comparing it to loaded data results. This process did not reveal 
any identifiable errors. Manual scanning also was performed on the data, crosschecking 
readmission information for other conditions, there was no change made to the original 
data when compare to the summary statistics report files provided by HCUP (2014 








4.1   Characteristics of TJA Discharges. 
We analyzed qualifying 935,391 TJA admissions in the United States between 
January and November of 2014. The national rate of 30-day readmission after primary 
TJA was 4% (95% confidence interval [CI], 3.9 - 4.1). The mean age for total joint 
arthroplasty patients was 66 years, and 68 years for those who were readmitted within 
30 days of the index admission (Table 5). However, this result may be due to the small 
variation in age within the vast majority of TJA patients. Among those patients 
readmitted, 57 % were female, 43 % male. Sixty-seven (67%) percent of the patients 
readmitted had Medicare as their primary insurance, 5% had Medicaid, 24% had private 
insurance, and 4% had other types of payments including self-pay and no charges. Thirty-
seven (37%) of the those readmitted had minor or no loss of function, 49% had a 
moderate loss of function , 12% had a major loss of function, and  2% had an extreme 
loss of function upon admission.  The most  common discharge disposition of the 
readmitted was to skilled nursing, and Intermediate care facilities (39%). Thirty-eight 
(38%) percent were discharged to home with home health-care agency services, and 22% 
were discharged to home without such services. Approximately half (49%) of the 





sized hospitals, and 20% were performed in small hospitals. Three-quarters (75%) of the 
readmitted TJAs were done in privately owned voluntary hospitals, 14% were performed 
in a private proprietary hospital, and only 10% of readmitted TJAs occurred in 
government nonfederal public hospitals. 
Table 4.1 Characteristics of TJA Discharges. 
 








Total N= 935,391 (100%)  N = 38,012 (100%) 
Mean age                             years (SD) 66   (10.4)    68   (11.4) 
Sex                               n (% of total)      
   Male 371,868    (40%) 16,337  (43%) 
  Female 561,474    (60%) 21,675  (57%) 
Primary Payer            n (% of total)   
  Medicare 522,153   (56%) 25,246  (67%) 
  Private Insurance 336,640   (35%)   9,483   (24%) 
  Medicaid 39,152   (5%)   1,952    (5%) 
  Other 35,434   (4%)   1,302    (4%) 
APR DRG                     n (% of total)   
 Minor 449,761    (49%) 13,943   (37%) 
 Moderate 436,699    (46%) 19,171   (49%) 
 Major 48,713    (5.6%)    4,676   (12%) 
Extreme 3329   (0.4%)        643   (2%) 
Hospital size by bed          n (% of total)   
  Small 227,331   (21%)   8,866    (20%) 
  Medium 271,633   (31%) 10,980    (31%) 
  Large 439,539   (48%) 18,587    (49%) 
Hospital type              n (% of total)   
  Public   89,728    (10 %)    3,837   (10%) 
  Voluntary 728,935    (73%) 29,082    (75%) 
  Proprietary 119,840    (16%)    5,515   (14%) 
Patient Disposition    n (% of total)   
 Home 273,135   (29 %)   8,656   (22%) 
 Skilled Nursing Facility (SNF), or (ICF)  247,038   (27%) 14,857   (39%) 
 Home Health Care (HHC) 412,984   (45%) 14,494   (38%) 






4.2   Most Common Diagnosis Associated with TJA. 
Consistent with previous studies, the most common diagnosis associated with 
joint arthroplasty in United States was osteoarthritis. Approximately 94 % of all 
discharges with TJA had an ICD-9 code for osteoarthritis ( Table 4.2 ) . Other conditions 
such as joint disorders, deformities, and rheumatoid arthritis were found with very 
limited frequency during the study period , which is consistent with other published 
literature on indications of total joint arthroplasty. 
Table 4.2 Diagnoses for patients undergoing primary TJA. 
 
Diagnosis Percentage 
Osteoarthritis 94 % 
Other bone disease and musculoskeletal deformities 2.2 % 
Fracture of neck of femur (hip) 1.3 % 
Other non-traumatic joint disorders 0.8 % 
Joint disorders and dislocations; trauma-related 0.5 % 
Rheumatoid arthritis and related disease 0.4 % 
 
 
             Source:  The National Readmission Database, 2014. 
 
4.3   Factors Associated with 30-day hospital readmission. 
Logistic regression was used to determine which factors had the greatest effect 
on readmission. Selected factors for this investigation included patient’s age, gender,  
type of insurance , discharge destination, and DRG severity. All these factors were 





that the study’s statistical power is sufficient to detect small differences. Thus, we 
examined each factor in greater detail by examining the odds ratios and crosstab 
frequencies. 
All patient-refined diagnosis-related group (ARP DRG) severity was added to the 
model to control for the severity of comorbid illness. Age had a minor effect on 
readmission, considering the odds ratio of 1.008 (Table 7). Female patients had a 22% 
lower risk  for readmission than the males. Patients who had Medicare as the primary 
payer had 34% higher risks, and those with Medicaid had a 74 % higher risk , while 
patients with other types of insurance, such as worker's compensation or other 
government programs , were at 27% higher risks for readmission when compared to 
patients with commercial insurance. 
Patients’ physiological status, which is measured by an APR DRG severity subclass, 
can have a significant effect on readmissions. Patients with a minor loss of function had a 
65% lower risk, and patients with a moderate level had a 52% lower risks, while patients 
with an extreme loss of function had a 90% higher risk of readmission when compared to 
patients with a major loss of function. 
Discharge disposition on post-hospitalization care can also have a significant 
effect on readmissions. Patients discharged to a skilled nursing or intermediate care 
facility were at 61% higher risk for hospital readmission, while those who were 
discharged to home health care services were at a 10% higher risk for readmission when 






Table 4.3 Factors associated with TJA readmission. 
 
Covariate 
OR                                         
( 95% CI ) 
OR Adjusted for 
Hospital Type (95% CI) 
Hospital Type       
p value 
    
Age  in years 1.008 (1.006 -1.010)* 1.008 (1.006-1.010) < 0.000 
Gender:    
  Male (reference) Ref   
  Female 0.782 (0.757-0.807)* 0.782 (0.755-0.804) < 0.000 
Insurance:    
  Private ( reference) Ref   
  Medicare  1.340 (1.282-1.400)* 1.328 (1.270-1.388) < 0.000 
  Medicaid 1.740 (1.615-1.874)* 1.728 (1.604-1.861) < 0.000 
  Other 1.275 (1.169-1.390)* 1.263 (1.158-1.378) < 0.000 
(APR DRG) Severity Subclass:    
  Major (reference) Ref   
  Minor 0.350 (0.332-0.369)* 0.347 (0.329-0.365) < 0.000 
  Moderate 0.480 (0.456-0.505)* 0.470 (0.454-0.503) < 0.000 
  Extreme  1.905 (1.667-2.191)* 1.893 (1.647-2.177) < 0.000 
Discharged to     
   Home (reference)       Ref   
  (SNF), or ( ICF)  1.614 (1.545-1.686)* 1.597 (1.528-1.668) < 0.000 
  Home Health care 1.090 (1.046-1.136)* 1.081 (1.037-1.126) < 0.000 
Hospital Size in beds:    
  Small ( reference)  Ref  
  Medium  1.054 (1.008-1.102) 0.019 
  Large  1.060 (1.018-1.106) 0.005 
Hospital Control/ownership:    
  Public ( reference)  Ref  
  Voluntary  0 .920 (0.877-0.972) 0.002 
  Proprietary  1.111 (1.045 -1.183) 0.001 
*Significant at the p<0.0001 level 
 HCUP National Readmission Database, 2014 






Readmission rates for different settings can be found in ( Figure 4.1) . TJA patients 
discharged to Home or Self Care (Routine Discharge) had the lowest rates of 30-day 
readmission at 3.13% in 2014. Therefore, we rejected our hypothesis # 1 that patients 
who received any form of post-acute care services are less like to be readmitted to a 
hospital within 30 days of discharge after TJA. 
Patients discharged to home with health agency services had a 3.52% readmission 
rate, while patients discharged to a skilled nursing facility or intermediate care facility 
had the highest 30-day readmission rate at 6.06 %. Therefore, we accepted our 
hypothesis #2 that patients who received post-acute care services at home are less likely 
to be readmitted to hospital within 30 days of discharge than those who were discharged 
to inpatient post-acute care settings. 
 
        
























SNF = Skilled Nursing Facility,   ICF = Intermediate Care Facility
HCUP National Readmission Database, 2014







We predicted that, due to HRRP and the Bundled Payments for Care 
Improvement (BPCI) initiatives, Medicare patients’ 30-day readmission rate would be 
lower than the rate for those who are commercially insured. However, Medicare patients 
had the second highest 30-day readmission rate at 4.86% (Figure 4.2) , while privately 




           
          Figure 4.2 Readmission rates by Payer Type. 
 
 
4.4   Study Limitations. 
The study analysis had several limitations. First, we limited the analysis to in-state 
























Other =  Worker's compensation or other Government programs
HCUP National Readmission Database, 2014







have been under-reported. Second, we found that the 30-day readmission rate for the 
privately insured population is considerably less than the Medicaid and Medicare 
population ( Figure 5), which may be to the fact that patients undergoing TJA who are 
covered by private insurance tends to be younger and healthier than patients on 
Medicare or Medicaid. Thus , the lower readmission rate by the privately insured patients 
tend to drive down the national readmission rates below what had been reported using  
the Medicare population alone (S. M. Kurtz et al., 2016a, 2016b), which corresponded to 
9.6%. However, the national readmission rates for TJA in our study are consistent with 
the findings of others(V. Avram et al., 2014; Jordan et al., 2012).  Also claims-based 
administrative data have the potential to contain errors associated with a recording 
diagnosis. However, healthcare cost and utilization project data are rigorously examined 
to ensure accuracy ,widely used to estimate diagnosis frequency, and utilized for public 
reporting. Third, because this study focused on index admissions, readmissions, and 
discharge disposition, other variables such as visits to emergency rooms, urgent care 
facilities, and outpatient centers, all of which are important in improving care transitions, 
were not available in the NRD. Fourth, index events were captured from January through 
November which allow a 30-day window from each hospital admission that could be used 
to search for readmissions. However, this approach could potentially mark a readmission 
in the first 30 day of the year as an index event, because data from the last month of the 









 This national study provides important insights into risk-adjusted TJA national 30-
day readmission rates in 2014 and looks closely at readmission risks among post-acute 
hospital discharge care settings. Discharge disposition can have a significant effect on the 
30-day readmission rate. Female patients had a 22% lower risks for readmission than the 
males. Patients discharged to a skilled nursing or intermediate care facility had a 61% 
higher risk for hospital readmission, while those who were discharged to home health 
care services had a 10% higher risk for readmission when compared to patients 
discharged to home with no further medical services. Patients who had Medicare as the 
primary payer had a 34% higher risk, and those with Medicaid had a 74 % higher risk, 
while patients with other types of insurance, such as worker's compensation or other 
government programs, had 27% higher risks for readmission when compared to patients 
with commercial insurance. 
              Our study has three key findings. First, TJA patients discharged to home tend to 
have the lowest rates of 30-day readmission. Second, patients who receive post-acute 
care services at home are less likely to be readmitted to the hospital as compared with 
those who received post-acute care at inpatient settings such as skilled nursing or 





Bundled Payments Models in the readmission rate and penalty formulas that can 
misrepresent health provider performance. Metrics used in the HRRP in rewarding and 
penalizing hospitals have a profound effect not just on what providers do, but also on 
what they choose to avoid doing. Refinements such as expanding the quality metrices 
used in HRRP to include post-acute care settings may better align program incentives 
between both types of providers (i.e., hospital and post-acute care providers) improve 
the HRRP and patients’ overall outcome of care through policy changes. Bundled 
payment has become a popular concept since introduced in the Patient Protection and 
Affordable Care Act of 2010, and the strategy has shown promise in reducing spending in 
some medical conditions. However, the implementation of a new payment method is 
complicated and healthcare providers are not universally enthusiastic to adopted. 
Hospitals, post-acute care providers, and patients can each influence readmission rates, 
and some readmission may be avoided through better planning to an adequate discharge 
destination and smoother transitions of care with the ultimate goal of improving both the 
efficiency of care delivery and patient experience of care. It would be better for post-
acute care providers and hospitals to become better aligned and incentivized to work 
together to improve care coordination. Also, by understanding factors that are associated 
with readmission, health policy can be further improved to avoid misaligned regulation 
and implement incentives to encourage better collaboration among all providers, thereby 
boosting the adoption of  evidenced-based clinical interventions to improve care and 








About the Partnership - Hospital Improvement Innovation Networks. (2017).   Retrieved 
from https://partnershipforpatients.cms.gov/about-the-partnership/hospital-
engagement-networks/thehospitalengagementnetworks.html 
Adelani, M. A., Keeney, J. A., Nunley, R. M., Clohisy, J. C., & Barrack, R. L. (2013). 
Readmission following total knee arthroplasty: venous thromboembolism as a 
"never event" is a counterproductive misnomer. J Arthroplasty, 28(5), 747-750. 
doi:10.1016/j.arth.2013.01.006 
Agency for Healthcare, R., Quality, C. f. D. O., Markets, H. C., & Utilization, P. (2013). All-
Cause Readmissions by Payer and Age, 2009-2013 #199.   Retrieved from 
https://www.hcup-us.ahrq.gov/reports/statbriefs/sb199-Readmissions-Payer-
Age.jsp 
Agency for Healthcare Research and Quality. (2018a). Nationwide Readmissions Database 
(NRD).   Retrieved from https://hcup-us.ahrq.gov/nrdoverview.jsp 
Agency for Healthcare Research and Quality. (2018b). NRD Summary Statistics.   
Retrieved from https://hcup-us.ahrq.gov/db/nation/nrd/nrdsummstats.jsp#2014 
Agency for Healthcare Research and Quality. (2018). Overview of Disease Severity 
Measures Disseminated with the Nationwide Inpatient Sample (NIS) and Kids' 
Inpatient Database (KID).   Retrieved from https://www.hcup-
us.ahrq.gov/db/nation/nis/severity_overview.jsp 
AMA. (2011). Examining the Drivers of Readmissions and Reducing Unnecessary 






American Academy of Orthopaedic Surgeons. (2018). Joint Replacement Surgery - 
OrthoInfo - AAOS.   Retrieved from 
https://orthoinfo.aaos.org/en/treatment/preparing-for-joint-replacement-
surgery/ 
Anandacoomarasamy, A., Fransen, M., & March, L. (2009). Obesity and the 
musculoskeletal system. Curr Opin Rheumatol, 21(1), 71-77.  
Arthritis. (2017). The Arthritis Foundation.   Retrieved from 
http://www.arthritis.org/about-arthritis/types/osteoarthritis/what-is-
osteoarthritis.php 
Ashton, C. M., & Wray, N. P. (1996). A conceptual framework for the study of early 
readmission as an indicator of quality of care. Social Science & Medicine, 43(11), 
1533-1541. doi:https://doi.org/10.1016/S0277-9536(96)00049-4 
Avram, V., Petruccelli, D., Winemaker, M., & de Beer, J. (2014). Total Joint Arthroplasty 
Readmission Rates and Reasons for 30-Day Hospital Readmission. The Journal of 
Arthroplasty, 29(3), 465-468. doi:https://doi.org/10.1016/j.arth.2013.07.039 
Avram, V., Petruccelli, D., Winemaker, M., & de Beer, J. (2014). Total joint arthroplasty 
readmission rates and reasons for 30-day hospital readmission. J Arthroplasty, 
29(3), 465-468. doi:10.1016/j.arth.2013.07.039 
Bisognano, M., & Boutwell, A. (2009). Improving transitions to reduce readmissions. Front 
Health Serv Manage, 25(3), 3-10.  
Blagojevic, M., Jinks, C., Jeffery, A., & Jordan, K. P. (2010). Risk factors for onset of 
osteoarthritis of the knee in older adults: a systematic review and meta-analysis. 
Osteoarthritis Cartilage, 18(1), 24-33. doi:10.1016/j.joca.2009.08.010 
Bosco, J. A., 3rd, Karkenny, A. J., Hutzler, L. H., Slover, J. D., & Iorio, R. (2014). Cost burden 
of 30-day readmissions following Medicare total hip and knee arthroplasty. J 
Arthroplasty, 29(5), 903-905. doi:10.1016/j.arth.2013.11.006 
Bozic, K. J., Maselli, J., Pekow, P. S., Lindenauer, P. K., Vail, T. P., & Auerbach, A. D. (2010). 





efficiency in total joint replacement surgery. J Bone Joint Surg Am, 92(16), 2643-
2652. doi:10.2106/jbjs.i.01477 
Bozic, K. J., Rubash, H. E., Sculco, T. P., & Berry, D. J. (2008). An Analysis of Medicare 
Payment Policy for Total Joint Arthroplasty. The Journal of Arthroplasty, 23(6, 
Supplement), 133-138. doi:http://dx.doi.org/10.1016/j.arth.2008.04.013 
Bozic, K. J., Ward, L., Vail, T. P., & Maze, M. (2014). Bundled payments in total joint 
arthroplasty: targeting opportunities for quality improvement and cost reduction. 
Clin Orthop Relat Res, 472(1), 188-193. doi:10.1007/s11999-013-3034-3 
Brady, O. H., Masri, B. A., Garbuz, D. S., & Duncan, C. P. (2000). Rheumatology: 10. Joint 
replacement of the hip and knee — when to refer and what to expect. CMAJ: 
Canadian Medical Association Journal, 163(10), 1285-1291.  
Buntin, M. B., Buntin, M. B., Deb, P., Deb, P., Escarce, J. J., Escarce, J. J., . . . Sood, N. 
(2005). Comparison of Medicare Spending and Outcomes for Beneficiaries with 
Lower Extremity Joint Replacements  Retrieved from 
https://www.rand.org/pubs/working_papers/WR271.html doi:WR271 
Buntin, M. B., Colla, C. H., & Escarce, J. J. (2009). Effects of payment changes on trends in 
post-acute care. Health Serv Res, 44(4), 1188-1210. doi:10.1111/j.1475-
6773.2009.00968.x 
Buntin, M. B., Garten, A. D., Paddock, S., Saliba, D., Totten, M., & Escarce, J. J. (2005). 
How much is postacute care use affected by its availability? Health Serv Res, 
40(2), 413-434. doi:10.1111/j.1475-6773.2005.00365.x 
Callahan, C. M., Drake, B. G., Heck, D. A., & Dittus, R. S. (1994). Patient outcomes 
following tricompartmental total knee replacement. A meta-analysis. JAMA, 
271(17), 1349-1357.  
Chassin, M. R., & Galvin, R. W. (1998). The urgent need to improve health care quality. 
Institute of Medicine National Roundtable on Health Care Quality. JAMA, 280(11), 
1000-1005.  
Chen, J. Y., Lo, N. N., Chong, H. C., Bin Abd Razak, H. R., Pang, H. N., Tay, D. K., . . . Yeo, S. 





life after total knee arthroplasty. Bone Joint J, 98-b(6), 780-785. 
doi:10.1302/0301-620x.98b6.35709 
Chimenti, C. E., & Ingersoll, G. (2007). Comparison of home health care physical therapy 
outcomes following total knee replacement with and without subacute 
rehabilitation. J Geriatr Phys Ther, 30(3), 102-108.  
Clement, R. C., Derman, P. B., Graham, D. S., Speck, R. M., Flynn, D. N., Levin, L. S., & 
Fleisher, L. A. (2013). Risk Factors, Causes, and the Economic Implications of 
Unplanned Readmissions Following Total Hip Arthroplasty. The Journal of 
Arthroplasty, 28(8, Supplement), 7-10. 
doi:https://doi.org/10.1016/j.arth.2013.04.055 
Clement, R. C., Kheir, M. M., Derman, P. B., Flynn, D. N., Speck, R. M., Levin, L. S., & 
Fleisher, L. A. (2014). What Are the Economic Consequences of Unplanned 
Readmissions After TKA? Clin Orthop Relat Res, 472(10), 3134-3141. 
doi:10.1007/s11999-014-3795-3 
CMS. (2016, 09/29/2016 12:59 PM). Partnership for Patients and the Hospital 
Improvement Innovation Networks.   Retrieved from 
https://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2016-Fact-
sheets-items/2016-09-29-2.html 
Cms.Gov. (2015, 11/16/2015 4:15 PM). Joint Replacement (CJR) Model.   Retrieved from 
https://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2015-Fact-
sheets-items/2015-11-16.html 
cms.gov. (2018, 04/17/2018 8:22 AM). National Health Expenditure Data.   Retrieved 
from https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-
Trends-and-Reports/NationalHealthExpendData/downloads/highlights.pdf 
Community-based Care Transitions Program | Center for Medicare & Medicaid 
Innovation. (2017).   Retrieved from https://innovation.cms.gov/initiatives/CCTP/ 
Cram, P., Lu, X., Kaboli, P. J., Vaughan-Sarrazin, M. S., Cai, X., Wolf, B., & Li, Y. (2011). 
Clinical characteristics and outcomes of Medicare patients undergoing total hip 






Cram, P., Lu, X., Kates, S. L., Singh, J. A., Li, Y., & Wolf, B. R. (2012). Total knee arthroplasty 
volume, utilization, and outcomes among Medicare beneficiaries, 1991-2010. 
JAMA, 308(12), 1227-1236. doi:10.1001/2012.jama.11153 
Desai, N. R., Ross, J. S., Kwon, J., & et al. (2016). Association between hospital penalty 
status under the hospital readmission reduction program and readmission rates 
for target and nontarget conditions. JAMA, 316(24), 2647-2656. 
doi:10.1001/jama.2016.18533 
Donabedian, A. (1966). Evaluating the quality of medical care. Milbank Mem Fund Q, 
44(3), Suppl:166-206.  
Dundon, J. M., Bosco, J., Slover, J., Yu, S., Sayeed, Y., & Iorio, R. (2016). Improvement in 
Total Joint Replacement Quality Metrics: Year One Versus Year Three of the 
Bundled Payments for Care Improvement Initiative. J Bone Joint Surg Am, 98(23), 
1949-1953. doi:10.2106/jbjs.16.00523 
Elixhauser, K. W. M., William, J. F., & Anne. (2017). Overview of Operating Room 
Procedures During Inpatient Stays in U.S. Hospitals, 2014. 
doi:https://www.ncbi.nlm.nih.gov/books/NBK487976/ 
Fang, M., Noiseux, N., Linson, E., & Cram, P. (2015). The Effect of Advancing Age on Total 
Joint Replacement Outcomes. Geriatric Orthopaedic Surgery & Rehabilitation, 
6(3), 173-179. doi:10.1177/2151458515583515 
Feinstein, A. R. (1970). THE PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN 
CHRONIC DISEASE. J Chronic Dis, 23(7), 455-468.  
Flegal, K. M., Carroll, M. D., Kit, B. K., & Ogden, C. L. (2012). Prevalence of obesity and 
trends in the distribution of body mass index among US adults, 1999-2010. JAMA, 
307(5), 491-497. doi:10.1001/jama.2012.39 
Flegal, K. M., Carroll, M. D., Ogden, C. L., & Curtin, L. R. (2010). Prevalence and trends in 






Gabriel, S. E., & Michaud, K. (2009). Epidemiological studies in incidence, prevalence, 
mortality, and comorbidity of the rheumatic diseases. Arthritis Research & 
Therapy, 11(3), 229-229. doi:10.1186/ar2669 
Gerhardt, G., Yemane, A., Hickman, P., Oelschlaeger, A., Rollins, E., & Brennan, N. (2013). 
Medicare readmission rates showed meaningful decline in 2012. Medicare 
Medicaid Res Rev, 3(2). doi:10.5600/mmrr.003.02.b01 
Gomez, P. F., & Morcuende, J. A. (2005). A Historical and Economic Perspective on Sir 
John Charnley, Chas F. Thackray Limited, and the Early Arthroplasty Industry. Iowa 
Orthop J, 25, 30-37.  
Guccione, A. A., Felson, D. T., Anderson, J. J., Anthony, J. M., Zhang, Y., Wilson, P. W., . . . 
Kannel, W. B. (1994). The effects of specific medical conditions on the functional 
limitations of elders in the Framingham Study. Am J Public Health, 84(3), 351-358.  
Gulland, A. (2014). Global life expectancy has risen, reports WHO. BMJ : British Medical 
Journal, 348. doi:10.1136/bmj.g3369 
Halfon, P., Eggli, Y., Pretre-Rohrbach, I., Meylan, D., Marazzi, A., & Burnand, B. (2006). 
Validation of the potentially avoidable hospital readmission rate as a routine 
indicator of the quality of hospital care. Med Care, 44(11), 972-981. 
doi:10.1097/01.mlr.0000228002.43688.c2 
Hawker, G., Wright, J., Coyte, P., Paul, J., Dittus, R., Croxford, R., . . . Freund, D. (1998). 
Health-related quality of life after knee replacement. J Bone Joint Surg Am, 80(2), 
163-173.  
Healthcare Cost and Utilization Project (HCUP) NRD Notes. (2018).   Retrieved from 
https://hcup-us.ahrq.gov/db/vars/aprdrg/nrdnote.jsp#general 
Hootman, J. M., & Helmick, C. G. (2006). Projections of US prevalence of arthritis and 
associated activity limitations. Arthritis Rheum, 54(1), 226-229. 
doi:10.1002/art.21562 
Hospital Readmission Reduction Program. (2015). doi:188895 
Järvenpää, J., Kettunen, J., Soininvaara, T., Miettinen, H., & Kröger, H. (2012). Obesity Has 





Scandinavian Journal of Surgery, 101(3), 198-203. 
doi:10.1177/145749691210100310 
Jauregui, J. J., Boylan, M. R., Kapadia, B. H., Naziri, Q., Maheshwari, A. V., & Mont, M. A. 
(2015). Total Joint Arthroplasty in Nonagenarians: What Are the Risks? The 
Journal of Arthroplasty, 30(12), 2102-2105.e2101. 
doi:https://doi.org/10.1016/j.arth.2015.06.028 
Jencks, S. F., Williams, M. V., & Coleman, E. A. (2009). Rehospitalizations among patients 
in the Medicare fee-for-service program. N Engl J Med, 360(14), 1418-1428. 
doi:10.1056/NEJMsa0803563 
Jordan, C. J., Goldstein, R. Y., Michels, R. F., Hutzler, L., Slover, J. D., & Bosco, J. A., 3rd. 
(2012). Comprehensive program reduces hospital readmission rates after total 
joint arthroplasty. Am J Orthop (Belle Mead NJ), 41(11), E147-151.  
Joynt, K. E., & Jha, A. K. (2013). Characteristics of hospitals receiving penalties under the 
hospital readmissions reduction program. JAMA, 309(4), 342-343. 
doi:10.1001/jama.2012.94856 
Kane, R. L., Chen, Q., Blewett, L. A., & Sangl, J. (1996). Do rehabilitative nursing homes 
improve the outcomes of care? J Am Geriatr Soc, 44(5), 545-554.  
Keehan, S. P., Cuckler, G. A., Sisko, A. M., Madison, A. J., Smith, S. D., Stone, D. A., . . . 
Lizonitz, J. M. (2015). National health expenditure projections, 2014-24: spending 
growth faster than recent trends. Health Aff (Millwood), 34(8), 1407-1417. 
doi:10.1377/hlthaff.2015.0600 
Keeney, J. A., Nam, D., Johnson, S. R., Nunley, R. M., Clohisy, J. C., & Barrack, R. L. (2015). 
The Impact of Risk Reduction Initiatives on Readmission: THA and TKA 
Readmission Rates. The Journal of Arthroplasty, 30(12), 2057-2060. 
doi:https://doi.org/10.1016/j.arth.2015.06.007 
Kelly, M. H., & Ackerman, R. M. (1999). Total joint arthroplasty: a comparison of 
postacute settings on patient functional outcomes. Orthop Nurs, 18(5), 75-84.  
Kenney, G. M., & Dubay, L. C. (1992). Explaining area variation in the use of Medicare 





Keswani, A., Tasi, M. C., Fields, A., Lovy, A. J., Moucha, C. S., & Bozic, K. J. (2016). 
Discharge Destination After Total Joint Arthroplasty: An Analysis of Postdischarge 
Outcomes, Placement Risk Factors, and Recent Trends. The Journal of 
Arthroplasty, 31(6), 1155-1162. doi:https://doi.org/10.1016/j.arth.2015.11.044 
King, H. B., Kesling, K., Birk, C., Walker, T., Taylor, H., Datena, M., . . . Bower, L. (2017). 
Leveraging the Partnership for Patients' Initiative to Improve Patient Safety and 
Quality Within the Military Health System. Mil Med, 182(3), e1612-e1619. 
doi:10.7205/milmed-d-16-00077 
Kurtz, S., Ong, K., Lau, E., Mowat, F., & Halpern, M. (2007). Projections of primary and 
revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone 
Joint Surg Am, 89(4), 780-785. doi:10.2106/jbjs.f.00222 
Kurtz, S. M., Lau, E., Ong, K., Zhao, K., Kelly, M., & Bozic, K. J. (2009). Future young patient 
demand for primary and revision joint replacement: national projections from 
2010 to 2030. Clin Orthop Relat Res, 467(10), 2606-2612. doi:10.1007/s11999-
009-0834-6 
Kurtz, S. M., Lau, E. C., Ong, K. L., Adler, E. M., Kolisek, F. R., & Manley, M. T. (2016a). 
Hospital, Patient, and Clinical Factors Influence 30- and 90-Day Readmission After 
Primary Total Hip Arthroplasty. The Journal of Arthroplasty, 31(10), 2130-2138. 
doi:https://doi.org/10.1016/j.arth.2016.03.041 
Kurtz, S. M., Lau, E. C., Ong, K. L., Adler, E. M., Kolisek, F. R., & Manley, M. T. (2016b). 
Which Hospital and Clinical Factors Drive 30- and 90-Day Readmission After TKA? 
The Journal of Arthroplasty, 31(10), 2099-2107. 
doi:http://dx.doi.org/10.1016/j.arth.2016.03.045 
Kurtz, S. M., Lau, E. C., Ong, K. L., Adler, E. M., Kolisek, F. R., & Manley, M. T. (2017a). 
Which Clinical and Patient Factors Influence the National Economic Burden of 
Hospital Readmissions After Total Joint Arthroplasty? Clin Orthop Relat Res, 
475(12), 2926-2937. doi:10.1007/s11999-017-5244-6 
Kurtz, S. M., Lau, E. C., Ong, K. L., Adler, E. M., Kolisek, F. R., & Manley, M. T. (2017b). 





Hospital Readmissions After Total Joint Arthroplasty? Clin Orthop Relat Res. 
doi:10.1007/s11999-017-5244-6 
Kurtz, S. M., Ong, K. L., Schmier, J., Mowat, F., Saleh, K., Dybvik, E., . . . Lau, E. (2007). 
Future clinical and economic impact of revision total hip and knee arthroplasty. J 
Bone Joint Surg Am, 89 Suppl 3, 144-151. doi:10.2106/jbjs.g.00587 
Lavernia, C. J., Laoruengthana, A., Contreras, J. S., & Rossi, M. D. (2009). All-Patient 
Refined Diagnosis-Related Groups in Primary Arthroplasty. The Journal of 
Arthroplasty, 24(6, Supplement), 19-23. 
doi:http://dx.doi.org/10.1016/j.arth.2009.03.008 
Lavernia, C. J., & Villa, J. M. (2015). Readmission Rates in Total Hip Arthroplasty: A 
Granular Analysis? J Arthroplasty, 30(7), 1127-1131. 
doi:10.1016/j.arth.2015.01.028 
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H., Deyo, R. A., . . . for 
the National Arthritis Data, W. (2008). Estimates of the Prevalence of Arthritis and 
Other Rheumatic Conditions in the United States, Part II. Arthritis Rheum, 58(1), 
26-35. doi:10.1002/art.23176 
Lementowski, P. W., & Zelicof, S. B. (2008). Obesity and osteoarthritis. Am J Orthop (Belle 
Mead NJ), 37(3), 148-151.  
Li, Y., Lu, X., Wolf, B. R., Callaghan, J. J., & Cram, P. (2013). Variation of Medicare 
payments for total knee arthroplasty. The Journal of Arthroplasty, 28(9), 1513-
1520. doi:10.1016/j.arth.2013.06.001 
Macera, C. A., Hootman, J. M., & Sniezek, J. E. (2003). Major public health benefits of 
physical activity. Arthritis Rheum, 49(1), 122-128. doi:10.1002/art.10907 
Maradit Kremers, H., Larson, D. R., Crowson, C. S., Kremers, W. K., Washington, R. E., 
Steiner, C. A., . . . Berry, D. J. (2015). Prevalence of Total Hip and Knee 






McCall, N., Korb, J., Petersons, A., & Moore, S. (2003). Reforming Medicare payment: 
early effects of the 1997 Balanced Budget Act on postacute care. Milbank Q, 
81(2), 277-303, 172-273.  
Medicare Program; Comprehensive Care for Joint Replacement Payment Model for Acute 
Care Hospitals Furnishing Lower Extremity Joint Replacement Services. Final rule. 
(2015). Fed Regist, 80(226), 73273-73554.  
Mesko, N. W., Bachmann, K. R., Kovacevic, D., LoGrasso, M. E., O’Rourke, C., & Froimson, 
M. I. (2014). Thirty-Day Readmission Following Total Hip and Knee Arthroplasty – 
A Preliminary Single Institution Predictive Model. The Journal of Arthroplasty, 
29(8), 1532-1538. doi:https://doi.org/10.1016/j.arth.2014.02.030 
Miric, A., Inacio, M. C. S., Kelly, M. P., & Namba, R. S. (2014). Can Total Knee Arthroplasty 
Be Safely Performed Among Nonagenarians? An Evaluation of Morbidity and 
Mortality Within a Total Joint Replacement Registry. The Journal of Arthroplasty, 
29(8), 1635-1638. doi:https://doi.org/10.1016/j.arth.2014.03.014 
Moore, C. M. T., & Brian, J. (2016). National Inpatient Hospital Costs: The Most Expensive 
Conditions by Payer, 2013. doi:https://www.ncbi.nlm.nih.gov/books/NBK368492/ 
Nadler, D., and Michael Tushman. (1988). Strategic Organization Design. Glenview, IL: 
Scott, Foresman and Company, 1988. 
Neu, C. R., Neu, C. R., Harrison, S., Harrison, S., Heilbrunn, J., & Heilbrunn, J. (1989). 
Medicare Patients and Postacute Care who Gose Where?  Retrieved from 
https://www.rand.org/pubs/reports/R3780.html. Also available in print form. 
doi:R3780 
NIH Consensus Statement on total knee replacement. (2003). NIH Consens State Sci 
Statements, 20(1), 1-34.  
Olthof, M., Stevens, M., Bulstra, S. K., & van den Akker-Scheek, I. (2014). The association 
between comorbidity and length of hospital stay and costs in total hip 






Oronce, C. I., Shao, H., & Shi, L. (2015). Disparities in 30-Day Readmissions After Total Hip 
Arthroplasty. Med Care, 53(11), 924-930. doi:10.1097/mlr.0000000000000421 
Parsons, I. M. t., & Sonnabend, D. H. (2004). What is the role of joint replacement 
surgery? Best Pract Res Clin Rheumatol, 18(4), 557-572. 
doi:10.1016/j.berh.2004.04.003 
Partnership for Patients | Center for Medicare & Medicaid Innovation. (2017).   Retrieved 
from https://innovation.cms.gov/initiatives/Partnership-for-Patients/ 
Paxton, E. W., Inacio, M. C. S., Singh, J. A., Love, R., Bini, S. A., & Namba, R. S. (2015). Are 
There Modifiable Risk Factors for Hospital Readmission After Total Hip 
Arthroplasty in a US Healthcare System? Clin Orthop Relat Res, 473(11), 3446-
3455. doi:10.1007/s11999-015-4278-x 
Pearson, S., Moraw, I., & Maddern, G. J. (2000). Clinical pathway management of total 
knee arthroplasty: a retrospective comparative study. Aust N Z J Surg, 70(5), 351-
354.  
Pivec, R., Johnson, A. J., Mears, S. C., & Mont, M. A. (2012). Hip arthroplasty. The Lancet, 
380(9855), 1768-1777. doi:http://dx.doi.org/10.1016/S0140-6736(12)60607-2 
Prevalence of disabilities and associated health conditions among adults—united states, 
1999. (2001). JAMA, 285(12), 1571-1000. doi:10.1001/jama.285.12.1571-
JWR0328-3-1 
Pugely, A. J., Callaghan, J. J., Martin, C. T., Cram, P., & Gao, Y. (2013). Incidence of and risk 
factors for 30-day readmission following elective primary total joint arthroplasty: 
analysis from the ACS-NSQIP. J Arthroplasty, 28(9), 1499-1504. 
doi:10.1016/j.arth.2013.06.032 
QualityNet - Measures. (2018).   Retrieved from 
https://www.qualitynet.org/dcs/ContentServer?c=Page&pagename=QnetPublic%
2FPage%2FQnetTier3&cid=1228776124964 







Ramos, N. L., Karia, R. J., Hutzler, L. H., Brandt, A. M., Slover, J. D., & Bosco, J. A. (2014). 
The Effect of Discharge Disposition on 30-Day Readmission Rates After Total Joint 
Arthroplasty. The Journal of Arthroplasty, 29(4), 674-677. 
doi:https://doi.org/10.1016/j.arth.2013.09.010 
Readmissions-Reduction-Program. (2016, 04/18/2016 5:08 PM).   Retrieved from 
https://www.cms.gov/Medicare/Medicare-Fee-for-Service-
Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html 
Salaffi, F., Carotti, M., Stancati, A., & Grassi, W. (2005). Health-related quality of life in 
older adults with symptomatic hip and knee osteoarthritis: a comparison with 
matched healthy controls. Aging Clin Exp Res, 17(4), 255-263.  
Saucedo, J. M., Marecek, G. S., Wanke, T. R., Lee, J., Stulberg, S. D., & Puri, L. (2014). 
Understanding Readmission After Primary Total Hip and Knee Arthroplasty: Who’s 
at Risk? The Journal of Arthroplasty, 29(2), 256-260. 
doi:http://dx.doi.org/10.1016/j.arth.2013.06.003 
Schaeffer, J. F., Scott, D. J., Godin, J. A., Attarian, D. E., Wellman, S. S., & Mather, R. C., 
3rd. (2015). The Association of ASA Class on Total Knee and Total Hip Arthroplasty 
Readmission Rates in an Academic Hospital. J Arthroplasty, 30(5), 723-727. 
doi:10.1016/j.arth.2014.12.014 
Schairer, W. W., Vail, T. P., & Bozic, K. J. (2014). What Are the Rates and Causes of 
Hospital Readmission After Total Knee Arthroplasty? Clin Orthop Relat Res, 472(1), 
181-187. doi:10.1007/s11999-013-3030-7 
Schneider, H., & Mathios, A. (2006). Principal Agency Theory and Health Care Utilization. 
Economic Inquiry, 44(3), 429-441. doi:10.1093/ei/cbj025 
Scuderi, G. R., Scott, W. N., & Tchejeyan, G. H. (2001). The Insall legacy in total knee 
arthroplasty. Clin Orthop Relat Res(392), 3-14.  







Shah, A. N., Vail, T. P., Taylor, D., & Pietrobon, R. (2004). Comorbid illness affects hospital 
costs related to hip arthroplasty: Quantification of health status and implications 
for fair reimbursement and surgeon comparisons1 1No benefits or funds were 
received in support of this study. The Journal of Arthroplasty, 19(6), 700-705. 
doi:https://doi.org/10.1016/j.arth.2004.02.034 
Sood, N., Huckfeldt, P. J., Escarce, J. J., Grabowski, D. C., & Newhouse, J. P. (2011). 
Medicare's bundled payment pilot for acute and postacute care: analysis and 
recommendations on where to begin. Health Aff (Millwood), 30(9), 1708-1717. 
doi:10.1377/hlthaff.2010.0394 
Stange, K. C. (2009). The Problem of Fragmentation and the Need for Integrative 
Solutions. Annals of Family Medicine, 7(2), 100-103. doi:10.1370/afm.971 
Steiner, K. R. F., Carol, S., Audrey, J. W., & Claudia, A. (2014). Most Frequent Operating 
Room Procedures Performed in U.S. Hospitals, 2003–2012. 
doi:https://www.ncbi.nlm.nih.gov/books/NBK274246/ 
Tribe, K. L., Lapsley, H. M., Cross, M. J., Courtenay, B. G., Brooks, P. M., & March, L. M. 
(2005). Selection of patients for inpatient rehabilitation or direct home discharge 
following total joint replacement surgery: a comparison of health status and out-
of-pocket expenditure of patients undergoing hip and knee arthroplasty for 
osteoarthritis. Chronic Illn, 1(4), 289-302. doi:10.1177/17423953050010041101 
Tsai , T. C., Joynt , K. E., Orav , E. J., Gawande , A. A., & Jha , A. K. (2013). Variation in 
Surgical-Readmission Rates and Quality of Hospital Care. New England Journal of 
Medicine, 369(12), 1134-1142. doi:doi:10.1056/NEJMsa1303118 
Tutorial, N. (2018). NRD Tutorial.   Retrieved from https://www.hcup-
us.ahrq.gov/tech_assist/nrd/index.html 
van Walraven, C., Bennett, C., Jennings, A., Austin, P. C., & Forster, A. J. (2011). 
Proportion of hospital readmissions deemed avoidable: a systematic review. 






Vorhies, J. S., Wang, Y., Herndon, J., Maloney, W. J., & Huddleston, J. I. (2011). 
Readmission and length of stay after total hip arthroplasty in a national Medicare 
sample. J Arthroplasty, 26(6 Suppl), 119-123. doi:10.1016/j.arth.2011.04.036 
Zuckerman, R. B., Sheingold, S. H., Orav, E. J., Ruhter, J., & Epstein, A. M. (2016). 
Readmissions, Observation, and the Hospital Readmissions Reduction Program. 







OVERVIEW OF KEY READMISSION MEASURES USED BY AHRQ 
 





Public reporting of the national burden of 30-day readmissions. 
The 
AHRQ-sponsored Web site HCUPnet (http://hcupnet.ahrq.gov) 
provides 










This measure is used to calculate national estimates of the 
percentage of 












HCUP readmission analysis file using the HCUP State Inpatient 
Databases (statewide hospital administrative data) weighted to 
calculate 

















Primary diagnosis and severity of illness were risk 
adjusted using the four levels of severity of illness (APR-DRGs) 
Severity of Illness. APR-DRGs were developed to reflect the 
clinical complexity of the patient population.   
Readmission rates were stratified by age, sex, expected payer, 
community income quartile, and metropolitan location. 
 
Reference 
A detailed description of the methodology for the HCUP 30-day 




   
Definition of Index Admission (Denominator for Rate) 
 




Index admissions are identified by major diagnostic category 
(MDC), 
diagnosis-related group (DRG), and AHRQ Clinical Classification 
Software (CCS) for principal diagnoses and all-listed procedures. 
 
All Patient Refined Diagnosis Related Groups (APR-DRGs) Version 
32.0 codes, (301 P 08 Hip Joint Replacement, and 302 P 08 Knee 









Transfers identified by one inpatient stay that ends on the same 
day as a 
second inpatient stay begins are allowed as an index admission, 
but they 
are only counted once. The information reported on the two 
discharges 
records related to the transfer is combined into a single inpatient 
event. 
 
The combined inpatient record is allowed to be an index 
admission. 
 
A patient is allowed to have multiple index admissions, 
regardless of how 
far apart they occur. In addition, a readmission can also count as 
an 






Patients discharged in December are excluded, because the 
HCUP 
databases are calendar-year files and December discharges 
could not be 
followed for 30 days. 
 





First admission that occurs within 30 days of an index admission 
with a 

















Principal diagnoses are Total Knee/Hip Arthroplasty. (ICD-9-CM) 
procedure codes 81.51 and 81.54 used to identify condition of 
interest (index events). While readmission reasons can by any 
thing that makes patient to come back to the hospital within 30-
days of the initial admission. 
 
Readmission rates reported on HCUPnet consider readmissions 
for the same condition and all causes. 
• For rates by MDC and DRG, readmissions for the same 
MDC or 
DRG and for all causes are considered. 
• For rates by principal diagnosis grouped by CCS, 
readmissions 
are considered for the same principal diagnosis CCS, for 
the 
same diagnosis CCS as a principal or secondary, and for 
all 
causes. 
• For reporting by procedure grouped by CCS, 
readmissions for all 









HCUP STATES PARTICIPATING IN THE 2014 NRD 
 
 
   Table B.1 HCUP Partners Participating in the 2014 NRD. 
State HCUP Data Source 
1. Arkansas  Arkansas Department of Health  
2. California  California Office of Statewide Health Planning and Development  
3. Florida  Florida Agency for Health Care Administration  
4. Georgia  Georgia Hospital Association  
5. Hawaii  Hawaii Health Information Corporation  
6. Iowa  Iowa Hospital Association  
7. Louisiana  Louisiana Department of Health and Hospitals  
8. Massachusetts  Massachusetts Center for Health Information and Analysis  
9. Maryland Maryland Health Services Cost Review Commission 
10. Missouri  Missouri Hospital Industry Data Institute  
11. Nebraska  Nebraska Hospital Association  
12. New Mexico  New Mexico Department of Health  
13. Nevada  Nevada Department of Health and Human Services  
14. New York  New York State Department of Health  
15. South Carolina  South Carolina Revenue and Fiscal Affairs Office  
16. South Dakota  South Dakota Association of Healthcare Organizations  
17. Tennessee  Tennessee Hospital Association  
18. Utah  Utah Department of Health  
19. Virginia  Virginia Health Information  
20. Vermont  Vermont Association of Hospitals and Health Systems  
21. Washington  Washington State Department of Health  


























Table B.2 Percentage of SID Discharges in the NRD by Type of Discharge. 
 
Type of Discharge  
Percentage of SID 
Discharges, 2014 
Included in the NRD  85.0 
Excluded from the NRD  15.0 
Hospital-level exclusions 
         Noncommunity hospitals  2.7 
         Rehabilitation or LTAC hospitals  0.2 
Discharge-level exclusions 
          Discharges from patients with an age of 0 (from 10 of 22 SID)  7.2 
          Discharges with missing or unverified patient linkage numbers  4.1 
          Questionable patient linkage numbers: same patient linkage number  
           on 20 or more discharges  
0.2 
          Questionable patient linkage numbers: patient is hospitalized after  
          discharged dead  
0.02 
          Questionable patient linkage numbers: overlapping inpatient stays  0.4 
           Discharges from hospitals with more than 50 percent of their total  
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 INTERVENTIONS TO REDUCE 30-DAY READMISSION RATE 
 
 
Table C.1 Interventions to reduce 30-day readmission rate. 
 
 
Interventions to reduce 30-day readmission rate 
 
 
Comprehensive program including four activities: 
1. Outpatient workup of venous thromboembolism. 
2. Decrease surgical site infection. 
3. Early follow-up with primary care physicians. 
4. Increase physician awareness of the financial and quality-related ramifications of 
unplanned readmission. (Jordan et al., 2012) 
 
 
Clinical Pathways for improving patient outcomes after knee arthroplasty (Pearson, 
Moraw, & Maddern, 2000) 
 
 
Evidence-based protocols and increasing care management services. 
30-day all-cause readmission rate decreased from 7% to 5%. (Dundon et al., 2016)  
 
 
Military Health System three initiatives: 
1. Communication, education, and improvement strategies. 
2. Evidence-based practices. 
3. Planning and Design. 
11% reduction in 30-day hospital readmission was achieved by the MHS.(King et al., 2017) 
 
 
